Adjunct Associate Professor

Dr Lisa Glen Horvath

medicine-health
St Vincent's Clinical School
Phone
02 9295 8323

Publications

  • Journal articles | 2021
    Dr Lisa Glen Horvath
    Wang Q; Guan YF; Hancock SE; Wahi K; van Geldermalsen M; Zhang BK; Pang A; Nagarajah R; Mak B; Freidman N; Horvath LG; Turner N; Holst J, 2021, 'Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth', Journal of Pathology, vol. 254, pp. 135 - 146, http://dx.doi.org/10.1002/path.5665
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Sweeney CJ; Martin AJ; Stockler MR; Begbie S; Chi KN; Chowdhury S; Coskinas X; Frydenberg M; Hague WE; Horvath LG; Joshua AM; Lawrence NJ; Marx GM; McCaffrey J; McDermott R; McJannett M; North SA; Parnis F; Parulekar W; Pook DW; Reaume MN; Sandhu SK; Tan A; Tan TH; Thomson A; Tu E; Vera-Badillo F; Williams SG; Yip S; Zhang AY; Zielinski RR; Davis ID, 2021, 'Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy', European Urology, http://dx.doi.org/10.1016/j.eururo.2021.05.016
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Wu SZ; Roden DL; Al-Eryani G; Bartonicek N; Harvey K; Cazet AS; Chan CL; Junankar S; Hui MN; Millar EA; Beretov J; Horvath L; Joshua AM; Stricker P; Wilmott JS; Quek C; Long GV; Scolyer RA; Yeung BZ; Segara D; Mak C; Warrier S; Powell JE; O’Toole S; Lim E; Swarbrick A, 2021, 'Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis', Genome Medicine, vol. 13, pp. 81, http://dx.doi.org/10.1186/s13073-021-00885-z
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Kwan EM; Fettke H; Crumbaker M; Docanto MM; To SQ; Bukczynska P; Mant A; Ng N; Foroughi S; Graham LJK; Haynes AM; Azer S; Lim LE; Segelov E; Mahon K; Davis ID; Parente P; Pezaro C; Todenhöfer T; Sathianathen N; Hauser C; Horvath LG; Joshua AM; Azad AA, 2021, 'Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer', Translational Andrology and Urology, vol. 10, pp. 1688 - 1699, http://dx.doi.org/10.21037/tau-20-1444
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Scheinberg T; Young A; Woo H; Goodwin A; Mahon KL; Horvath LG, 2021, 'Mainstream consent programs for genetic counseling in cancer patients: A systematic review', Asia-Pacific Journal of Clinical Oncology, vol. 17, pp. 163 - 177, http://dx.doi.org/10.1111/ajco.13334
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Lin HM; Huynh K; Kohli M; Tan W; Azad AA; Yeung N; Mahon KL; Mak B; Sutherland PD; Shepherd A; Mellett N; Docanto M; Giles C; Centenera MM; Butler LM; Meikle PJ; Horvath LG, 2021, 'Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer', Prostate Cancer and Prostatic Diseases, http://dx.doi.org/10.1038/s41391-021-00338-z
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Olama AAA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokołorczyk D; Lubiński J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Røder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordström T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin HY; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IM; Hamilton RJ; Fleshner NE; Finelli A; Parent MÉ; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Håkansson N; Andriole GL; Hoover RN; Machiela MJ; Sørensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu YJ, 2021, 'Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction', Nature Genetics, vol. 53, pp. 65 - 75, http://dx.doi.org/10.1038/s41588-020-00748-0
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Sarkar S; Tran B; Horvath L; Lam M; Savas P; Grimison P; Whittle JR; Kuo JC; Signal N; Edmonds D; Hogg P; Rischin D; Desai J; Hamilton A, 2021, 'A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours', Cancer Chemotherapy and Pharmacology, vol. 87, pp. 613 - 620, http://dx.doi.org/10.1007/s00280-020-04225-7
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Kwan EM; Fettke H; Docanto MM; To SQ; Bukczynska P; Mant A; Pook D; Ng N; Graham LJK; Mangiola S; Segelov E; Mahon K; Davis ID; Parente P; Pezaro C; Todenhöfer T; Horvath LG; Azad AA, 2021, 'Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer', European Urology Focus, vol. 7, pp. 63 - 70, http://dx.doi.org/10.1016/j.euf.2019.04.020
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Olama AAA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokołorczyk D; Lubiński J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Røder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordström T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin HY; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IM; Hamilton RJ; Fleshner NE; Finelli A; Parent MÉ; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Håkansson N; Andriole GL; Hoover RN; Machiela MJ; Sørensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu YJ, 2021, 'Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0)', Nature Genetics, vol. 53, pp. 413, http://dx.doi.org/10.1038/s41588-021-00786-2
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2021, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, http://dx.doi.org/10.1007/s11764-021-01012-y
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Scheinberg T; Goodwin A; Ip E; Linton A; Mak B; Smith DP; Stockler MR; Strach MC; Tran B; Young AL; Zhang AY; Mahon KL; Horvath LG, 2021, 'Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer', JCO oncology practice, vol. 17, pp. e204 - e216, http://dx.doi.org/10.1200/OP.20.00399
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Kwan EM; Dai C; Fettke H; Hauser C; Docanto MM; Bukczynska P; Ng N; Foroughi S; Graham L-JK; Mahon K; Tan W; Wang X; Zhao Z; Zheng T; Zhou K; Yu J; Du P; Horvath LG; Jia S; Kohli M; Azad AA, 2021, 'Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate Cancer.', JCO Precis Oncol, vol. 5, pp. 622 - 637, http://dx.doi.org/10.1200/PO.20.00424
    Journal articles | 2021
    Dr Lisa Glen Horvath
    Sutherland SIM; Ju X; Horvath LG; Clark GJ, 2021, 'Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer', Frontiers in Immunology, vol. 12, http://dx.doi.org/10.3389/fimmu.2021.641307
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Hollis B; Day FR; Busch AS; Thompson DJ; Soares ALG; Timmers PRHJ; Kwong A; Easton DF; Joshi PK; Timpson NJ; Eeles RA; Henderson BE; Haiman CA; Kote-Jarai Z; Schumacher FR; Olama AAA; Benlloch S; Muir K; Berndt SI; Conti DV; Wiklund F; Chanock S; Gapstur S; Stevens VL; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Albanes D; Wolk A; West C; Mucci L; Cancel-Tassin G; Koutros S; Sorensen KD; Grindedal EM; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Ingles SA; Rosenstein BS; Lu YJ; Giles GG; Kibel AS; Vega A; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; John EM; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright L; Pandha H; Thibodeau SN; Agee M; Alipanahi B; Auton A; Bell RK; Bryc K; Elson SL; Fontanillas P; Furlotte NA; Hinds DA; Huber KE; Kleinman A; Litterman NK; McIntyre MH; Mountain JL; Noblin ES; Northover CAM; Pitts SJ; Sathirapongsasuti JF; Sazonova OV; Shelton JF; Shringarpure S; Tian C; Tung JY; Vacic V, 2020, 'Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan', Nature Communications, vol. 11, http://dx.doi.org/10.1038/s41467-020-14451-5
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Kohli M; Tan W; Zheng T; Wang A; Montesinos C; Wong C; Du P; Jia S; Yadav S; Horvath LG; Mahon KL; Kwan EM; Fettke H; Yu J; Azad AA, 2020, 'Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer', EBioMedicine, vol. 54, http://dx.doi.org/10.1016/j.ebiom.2020.102728
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LJK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA, 2020, 'Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer', European Urology, vol. 78, pp. 173 - 180, http://dx.doi.org/10.1016/j.eururo.2020.03.044
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Desai J; Deva S; Lee JS; Lin CC; Yen CJ; Chao Y; Keam B; Jameson M; Hou MM; Kang YK; Markman B; Lu CH; Rau KM; Lee KH; Horvath L; Friedlander M; Hill A; Sandhu S; Barlow P; Wu CY; Zhang Y; Liang L; Wu J; Paton V; Millward M, 2020, 'Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors', Journal for ImmunoTherapy of Cancer, vol. 8, http://dx.doi.org/10.1136/jitc-2019-000453
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Scheinberg T; Kench J; Stockler M; Mahon KL; Sebastian L; Stricker P; Joshua AM; Woo H; Thanigasalam R; Ahmadi N; Centenera MM; Butler LM; Horvath LG, 2020, 'Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: A study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)', BMJ Open, vol. 10, http://dx.doi.org/10.1136/bmjopen-2019-033667
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Wu S; Roden D; Al-Eryani G; Bartonicek N; Harvey K; Cazet A; Chan C-L; Junankar S; Hui M; Millar E; Beretov J; Horvath L; Joshua A; Stricker P; Wilmott J; Quek C; Long G; Scolyer R; Yeung B; Segara D; Mak C; Warrier S; Powell J; O'Toole S; Lim E; Swarbrick A, 2020, 'Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis', bioRxiv, http://dx.doi.org/10.1101/2020.06.04.135277
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Desai J; Gan H; Barrow C; Jameson M; Atkinson V; Haydon A; Millward M; Begbie S; Brown M; Markman B; Patterson W; Hill A; Horvath L; Nagrial A; Richardson G; Jackson C; Friedlander M; Parente P; Tran B; Wang L; Chen Y; Tang Z; Huang W; Wu J; Zeng D; Luo L; Solomon B, 2020, 'Phase I, open-label, dose-escalation/ dose-expansion study of lifirafenib (BGB-283), an RAF family kinase inhibitor, in patients with solid tumors', Journal of Clinical Oncology, vol. 38, pp. 2140 - 2150, http://dx.doi.org/10.1200/JCO.19.02654
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Nassar ZD; Mah CY; Dehairs J; Burvenich IJG; Irani S; Centenera MM; Helm M; Shrestha RK; Moldovan M; Don AS; Holst J; Scott AM; Horvath LG; Lynn DJ; Selth LA; Hoy AJ; Swinnen JV; Butler LM, 2020, 'Human decr1 is an androgen-repressed survival factor that regulates pufa oxidation to protect prostate tumor cells from ferroptosis', eLife, vol. 9, pp. 1 - 34, http://dx.doi.org/10.7554/eLife.54166
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Timmins HC; Li T; Kiernan MC; Horvath LG; Goldstein D; Park SB, 2020, 'Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients', Journal of Pain, vol. 21, pp. 44 - 58, http://dx.doi.org/10.1016/j.jpain.2019.06.011
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Niazi T; Williams S; Davis ID; Stockler MR; Martin AJ; Hague W; Bracken K; Gorzeman M; Roncolato F; Yip S; Horvath L; Sengupta S; Hughes S; McDermott RS; Catto JWF; Vapiwala N; Parulekar WR; Sweeney C, 2020, 'DASL-HiCAP (ANZUP1801): The impact of darolutamide on standard therapy for localized very high-risk cancer of the prostate—A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high-risk, clinically localized prostate cancer.', Journal of Clinical Oncology, vol. 38, pp. TPS385 - TPS385, http://dx.doi.org/10.1200/jco.2020.38.6_suppl.tps385
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Tran B; Horvath L; Dorff TB; Greil R; Machiels J-PH; Roncolato F; Autio KA; Rettig M; Fizazi K; Lolkema MP; Fermin AC; Salvati M; Kouros-Mehr H, 2020, 'Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy targeting prostate-specific membrane antigen (PSMA), in patients with metastatic castration-resistant prostate cancer (mCRPC).', Journal of Clinical Oncology, vol. 38, pp. TPS261 - TPS261, http://dx.doi.org/10.1200/jco.2020.38.6_suppl.tps261
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Miladinovic D; Cusick T; Mahon KL; Haynes AM; Cortie CH; Meyer BJ; Stricker PD; Wittert GA; Butler LM; Horvath LG; Hoy AJ, 2020, 'Assessment of periprostatic and subcutaneous adipose tissue lipolysis and adipocyte size from men with localized prostate cancer', Cancers, vol. 12, http://dx.doi.org/10.3390/cancers12061385
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Scheinberg T; Goodwin A; Ip E; Linton A; Mak B; Smith DP; Stockler MR; Strach MC; Tran B; Young AL; Zhang AY; Mahon KL; Horvath L, 2020, 'Evaluation of a mainstream model of genetic testing for men with prostate cancer.', Journal of Clinical Oncology, vol. 38, pp. 1521 - 1521, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1521
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Riedl JM; Posch F; Horvath L; Gantschnigg A; Renneberg F; Schwarzenbacher E; Moik F; Barth D; Stotz M; Schaberl-Moser R; Pichler M; Stöger H; Greil R; Djanani A; Schlick K; Gerger A, 2020, '1530P Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis', Annals of Oncology, vol. 31, pp. S942 - S942, http://dx.doi.org/10.1016/j.annonc.2020.08.2013
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Voskoboynik M; Richardson GE; Mileshkin LR; McNeil CM; Horvath L; Benedetti FM; Choy GS; Sankar N; McCurry S; Zhang X; Gao M; Shah AK; Millward M, 2020, 'A phase I study of APL-501, an anti-PD-1 antibody, in patients with recurrent or advanced solid tumors.', Journal of Clinical Oncology, vol. 38, pp. e15125 - e15125, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e15125
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Schwarzenbacher E; Moik F; Posch F; Horvath L; Gantschnigg A; Renneberg F; Barth D; Stotz M; Schaberl-Moser R; Pichler M; Ay C; Stöger H; Greil R; Djanani A; Gerger A; Schlick K; Riedl JM, 2020, '1552P Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX', Annals of Oncology, vol. 31, pp. S949 - S950, http://dx.doi.org/10.1016/j.annonc.2020.08.2035
    Journal articles | 2020
    Dr Lisa Glen Horvath
    Li T; Timmins HC; McCrary JM; Trinh T; Horvath LG; Friedlander ML; Kiernan MC; Goldstein D; Park SB, 2020, '5. Neurophysiological characteristics in the development and recovery of peripheral neuropathy in oxaliplatin and paxlitaxel treated patients', Clinical Neurophysiology, vol. 131, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2019.11.038
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Balaban S; Nassar ZD; Zhang AY; Hosseini-Beheshti E; Centenera MM; Schreuder M; Lin HM; Aishah A; Varney B; Liu-Fu F; Lee LS; Nagarajan SR; Shearer RF; Hardie RA; Raftopulos NL; Kakani MS; Saunders DN; Holst J; Horvath LG; Butler LM; Hoy AJ, 2019, 'Extracellular fatty acids are the major contributor to lipid synthesis in prostate cancer', Molecular Cancer Research, vol. 17, pp. 949 - 962, http://dx.doi.org/10.1158/1541-7786.MCR-18-0347
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Gamell C; Bandilovska I; Gulati T; Kogan A; Lim SC; Kovacevic Z; Takano EA; Timpone C; Agupitan AD; Litchfield C; Blandino G; Horvath LG; Fox SB; Williams SG; Russo A; Gallo E; Paul PJ; Mitchell C; Sandhu S; Keam SP; Haupt S; Richardson DR; Haupt Y, 2019, 'E6AP Promotes a Metastatic Phenotype in Prostate Cancer', iScience, vol. 22, pp. 1 - 15, http://dx.doi.org/10.1016/j.isci.2019.10.065
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Schumacher FR; Olama AAA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Håkansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Beane Freeman LE; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C, 2019, 'Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8)', Nature Genetics, vol. 51, pp. 363, http://dx.doi.org/10.1038/s41588-018-0330-6
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Quinn DI; Stricker PD; Kench JG; Grogan J; Haynes AM; Henshall SM; Grygiel JJ; Delprado W; Turner JJ; Horvath LG; Mahon KL, 2019, 'p53 nuclear accumulation as an early indicator of lethal prostate cancer', British Journal of Cancer, vol. 121, pp. 578 - 583, http://dx.doi.org/10.1038/s41416-019-0549-8
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Zhang AY; Chiam K; Haupt Y; Fox S; Birch S; Tilley W; Butler LM; Knudsen K; Comstock C; Rasiah K; Grogan J; Mahon KL; Bianco-Miotto T; Ricciardelli C; Böhm M; Henshall S; Delprado W; Stricker P; Horvath LG; Kench JG, 2019, 'An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy', International Journal of Cancer, vol. 144, pp. 1151 - 1159, http://dx.doi.org/10.1002/ijc.31906
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Sweeney C; Martin AJ; Zielinski RR; Thomson A; Tan TH; Sandhu SK; Reaume MN; Pook DW; Parnis F; North SA; McDermott R; McCaffrey J; Marx GM; Lawrence NJ; Horvath L; Frydenberg M; Chowdhury S; Chi KN; Stockler MR; Davis ID, 2019, 'Overall survival (OS) results of a phase III randomized trial of standard-of-care therapy with or without enzalutamide for metastatic hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led international cooperative group trial.', Journal of Clinical Oncology, vol. 37, pp. LBA2 - LBA2, http://dx.doi.org/10.1200/jco.2019.37.18_suppl.lba2
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Stockler MR; Martin AJ; Dhillon H; Davis ID; Chi KN; Chowdhury S; Horvath LG; Lawrence NJ; Marx GM; Caffrey JM; McDermott R; North SA; Parnis F; Pook DW; Reaume MN; Sandhu SK; Tan TH; Thomson A; Zielinski R; Sweeney CJ, 2019, 'Health-related quality of life (HRQL) in a randomized phase III trial of enzalutamide with standard first-line therapy for metastatic, hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led, international, co-operative group trial', Annals of Oncology, vol. 30, pp. v886 - v887, http://dx.doi.org/10.1093/annonc/mdz394.046
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Stradella A; Johnson ML; Goel S; Chandana SR; Galsky MD; Calvo E; Moreno V; Park H; Arkenau H-T; Cervantes A; Madrid LF; Mileshkin L; Plummer R; Evans J; Horvath L; Prawira A; Pelham RJ; Mu S; Andreu-Vieyra C; Barve M, 2019, 'Updated results of the PARP1/2 inhibitor pamiparib in combination with low-dose (ld) temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumours', Annals of Oncology, vol. 30, pp. v166 - v167, http://dx.doi.org/10.1093/annonc/mdz244.013
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Emmett L; Crumbaker M; Ho B; Willowson K; Eu P; Ratnayake L; Epstein R; Blanksby A; Horvath L; Guminski A; Mahon K; Gedye C; Yin C; Stricker P; Joshua AM, 2019, 'Results of a Prospective Phase 2 Pilot Trial of 177 Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression', Clinical Genitourinary Cancer, vol. 17, pp. 15 - 22, http://dx.doi.org/10.1016/j.clgc.2018.09.014
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Emmett L; Yin C; Crumbaker M; Hruby G; Kneebone A; Epstein R; Nguyen Q; Hickey A; Ihsheish N; O'Neill G; Horvath L; Chalasani V; Stricker P; Joshua AM, 2019, 'Rapid modulation of PSMA expression by androgen deprivation: Serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade', Journal of Nuclear Medicine, vol. 60, pp. 950 - 954, http://dx.doi.org/10.2967/jnumed.118.223099
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Davis ID; Martin AJ; Stockler MR; Begbie S; Chi KN; Chowdhury S; Coskinas X; Frydenberg M; Hague WE; Horvath LG; Joshua AM; Lawrence NJ; Marx G; McCaffrey J; McDermott R; McJannett M; North SA; Parnis F; Parulekar W; Pook DW; Neil Reaume M; Sandhu SK; Tan A; Hsiang Tan T; Thomson A; Tu E; Vera-Badillo F; Williams SG; Yip S; Zhang AY; Zielinski RR; Sweeney CJ, 2019, 'Enzalutamide with standard first-line therapy in metastatic prostate cancer', New England Journal of Medicine, vol. 381, pp. 121 - 131, http://dx.doi.org/10.1056/NEJMoa1903835
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Crumbaker M; Emmett L; Horvath LG; Joshua AM, 2019, 'Exceptional response to 177lutetium prostate-specific membrane antigen in prostate cancer harboring DNA repair defects', JCO Precision Oncology, vol. 3, http://dx.doi.org/10.1200/PO.18.00237
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Castillo L; George S; Lin H-M; Yeung N; Mawson A; Young AI; Law AM; Hastings J; Gallego-Ortega D; Deng N; Croucher D; Swarbrick A; Horvath L; Ormandy CJ; Oakes SR, 2019, 'Flicking the switch off, targeting MCL-1 in the treatment of breast and prostate cancer', Oncology Abstracts, http://dx.doi.org/10.1530/oncolabs.1.p038
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Olama AAA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu YJ; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; Henderson BE; Stern MC; Thwaites A; Guy M; Whitmore I; Morgan A; Fisher C; Hazel S; Livni N; Cook M; Fachal L; Weinstein S; Beane Freeman LE; Hoover RN; Machiela MJ; Lophatananon A; Carter BD; Goodman P; Moya L; Srinivasan S; Kedda MA; Yeadon T; Eckert A; Eklund M; Cavalli-Bjoerkman C; Dunning AM; Sipeky C; Hakansson N; Elliott R; Ranu H, 2019, 'Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)', Nature Communications, vol. 10, http://dx.doi.org/10.1038/s41467-019-08293-z
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ, 2019, 'Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target', Neoplasia (United States), vol. 21, pp. 389 - 400, http://dx.doi.org/10.1016/j.neo.2019.02.005
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Skvortsova K; Masle-Farquhar E; Luu PL; Song JZ; Qu W; Zotenko E; Gould CM; Du Q; Peters TJ; Colino-Sanguino Y; Pidsley R; Nair SS; Khoury A; Smith GC; Miosge LA; Reed JH; Kench JG; Rubin MA; Horvath L; Bogdanovic O; Lim SM; Polo JM; Goodnow CC; Stirzaker C; Clark SJ, 2019, 'DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns', Cancer Cell, vol. 35, pp. 297 - 314.e8, http://dx.doi.org/10.1016/j.ccell.2019.01.004
    Journal articles | 2019
    Dr Lisa Glen Horvath
    McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB, 2019, 'Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, vol. 27, pp. 3849 - 3857, http://dx.doi.org/10.1007/s00520-019-04680-w
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Mahon KL; Qu W; Lin HM; Spielman C; Cain D; Jacobs C; Stockler MR; Higano CS; de Bono JS; Chi KN; Clark SJ; Horvath LG, 2019, 'Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial', European Urology, vol. 76, pp. 306 - 312, http://dx.doi.org/10.1016/j.eururo.2018.11.001
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Tran B; Kouros-Mehr H; Fermin A; Horvath L; Roncolato F; Rettig M; Dorff T; Tagawa ST; Subudhi SK; Antonarakis ES; Armstrong AJ; Petrylak DP; Fizazi K; Salvati ME; Scher HI, 2019, 'A phase I study of AMG 160, a half-life extended bispecific T cell engager (HLE BiTE) immuno-oncology therapy targeting PSMA, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)', Annals of Oncology, vol. 30, pp. v353 - v353, http://dx.doi.org/10.1093/annonc/mdz248.052
    Journal articles | 2019
    Dr Lisa Glen Horvath
    Gillessen S; Horvath LG, 2019, 'Statins – No more cream for cancer', European Journal of Cancer, vol. 112, pp. 107 - 108, http://dx.doi.org/10.1016/j.ejca.2019.02.008
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Roohullah A; Cooper A; Lomax AJ; Aung J; Barge A; Chow L; McHale M; Desai J; Whittle JR; Tran B; de Souza P; Horvath LG, 2018, 'A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers', Investigational New Drugs, vol. 36, pp. 886 - 894, http://dx.doi.org/10.1007/s10637-018-0588-7
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Olama AAA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu YJ; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Dominguez MG; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; Henderson BE; Stern MC; Thwaites A; Guy M; Whitmore I; Morgan A; Fisher C; Hazel S; Livni N; Cook M; Fachal L; Weinstein S; Beane Freeman LE; Hoover RN; Machiela MJ; Lophatananon A; Carter BD; Goodman P; Moya L; Srinivasan S; Kedda MA; Yeadon T; Eckert A; Eklund M; Cavalli-Bjoerkman C; Dunning AM; Sipeky C; Hakansson N; Elliott R; Ranu H, 2018, 'Germline variation at 8q24 and prostate cancer risk in men of European ancestry', Nature Communications, vol. 9, http://dx.doi.org/10.1038/s41467-018-06863-1
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Håkansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Beane Freeman LE; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; Fitzgerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C, 2018, 'Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci', Nature Genetics, vol. 50, pp. 928 - 936, http://dx.doi.org/10.1038/s41588-018-0142-8
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Nguyen EV; Centenera MM; Moldovan M; Das R; Irani S; Vincent AD; Chan H; Horvath LG; Lynn DJ; Daly RJ; Butler LM, 2018, 'Identification of novel response and predictive biomarkers to Hsp90 inhibitors through proteomic profiling of patient-derived prostate tumor explants', Molecular and Cellular Proteomics, vol. 17, pp. 1470 - 1486, http://dx.doi.org/10.1074/mcp.RA118.000633
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Olama AAA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; Fitzgerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA, 2018, 'Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants', Nature Communications, vol. 9, http://dx.doi.org/10.1038/s41467-018-04109-8
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Lin HM; Nikolic I; Yang J; Castillo L; Deng N; Chan CL; Yeung NK; Dodson E; Elsworth B; Spielman C; Lee BY; Boyer Z; Simpson KJ; Daly RJ; Horvath LG; Swarbrick A, 2018, 'MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer', Scientific Reports, vol. 8, http://dx.doi.org/10.1038/s41598-018-26050-y
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Vafaee F; Diakos C; Kirschner M; Reid G; Michael M; Horvath LISA; Alinejad-Rokny H; Cheng ZJ; Kuncic Z; Clarke S, 2018, 'A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis', npj Systems Biology and Applications, vol. 4, pp. 20 - 20, http://dx.doi.org/10.1038/s41540-018-0056-1
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Lin HM; Lee BY; Castillo L; Spielman C; Grogan J; Yeung NK; Kench JG; Stricker PD; Haynes AM; Centenera MM; Butler LM; Shreeve SM; Horvath LG; Daly RJ, 2018, 'Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer', Prostate, vol. 78, pp. 308 - 317, http://dx.doi.org/10.1002/pros.23476
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Kalsbeek AMF; Chan EKF; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM, 2018, 'Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer', Prostate, vol. 78, pp. 25 - 31, http://dx.doi.org/10.1002/pros.23440
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Nair SS; Luu PL; Qu W; Maddugoda M; Huschtscha L; Reddel R; Chenevix-Trench G; Toso M; Kench JG; Horvath LG; Hayes VM; Stricker PD; Hughes TP; White DL; Rasko JEJ; Wong JJL; Clark SJ, 2018, 'Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten', Epigenetics and Chromatin, vol. 11, http://dx.doi.org/10.1186/s13072-018-0194-0
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Pidsley R; Lawrence MG; Zotenko E; Niranjan B; Statham A; Song J; Chabanon RM; Qu W; Wang H; Richards M; Nair SS; Armstrong NJ; Nim HT; Papargiris M; Balanathan P; French H; Peters T; Norden S; Ryan A; Pedersen J; Kench J; Daly RJ; Horvath LG; Stricker P; Frydenberg M; Taylor RA; Stirzaker C; Risbridger GP; Clark SJ, 2018, 'Enduring epigenetic landmarks define the cancer microenvironment', Genome Research, vol. 28, pp. 625 - 638, http://dx.doi.org/10.1101/gr.229070.117
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Deva S; Lee J-S; Lin C-C; Yen C-J; Millward M; Chao Y; Keam B; Jameson M; Hou M-M; Kang Y-K; Markman B; Lu C-H; Rau K-M; Lee K-H; Horvath L; Friedlander M; Hill A; Wu J; Hou J; Desai J, 2018, 'A phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors', Annals of Oncology, vol. 29, pp. x24 - x25, http://dx.doi.org/10.1093/annonc/mdy487.042
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Smith MR; Saad F; Chowdhury S; Oudard S; Hadaschik BA; Graff JN; Olmos D; Mainwaring PN; Lee JY; Uemura H; Lopez-Gitlitz A; Trudel GC; Espina BM; Shu Y; Park YC; Rackoff WR; Yu MK; Small EJ, 2018, 'Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer', New England Journal of Medicine, vol. 378, pp. 1408 - 1418, http://dx.doi.org/10.1056/nejmoa1715546
    Journal articles | 2018
    Dr Lisa Glen Horvath
    Timmins HC; Li T; Grimison P; Murray JE; Cox KM; Horvath LG; Lewis CR; Goldstein D; Kiernan MC; Park SB, 2018, '5. Neurophysiological dysfunction in chemotherapy-treated patients: Comparison of different platinum analogues', Clinical Neurophysiology, vol. 129, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.018
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Quinn DI; Sandler HM; Horvath LG; Goldkorn A; Eastham JA, 2017, 'The evolution of chemotherapy for the treatment of prostate cancer', Annals of Oncology, vol. 28, pp. 2658 - 2669, http://dx.doi.org/10.1093/annonc/mdx348
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Barnet MB; O'Toole S; Horvath LG; Selinger C; Yu B; Ng CC; Boyer M; Cooper WA; Kao S, 2017, 'EGFR–Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors', Journal of Thoracic Oncology, vol. 12, pp. 585 - 590, http://dx.doi.org/10.1016/j.jtho.2016.09.001
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Lin HM; Mahon KL; Spielman C; Gurney H; Mallesara G; Stockler MR; Bastick P; Briscoe K; Marx G; Swarbrick A; Horvath LG, 2017, 'Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer', British Journal of Cancer, vol. 116, pp. 1002 - 1011, http://dx.doi.org/10.1038/bjc.2017.50
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Lin HM; Mahon KL; Weir JM; Mundra PA; Spielman C; Briscoe K; Gurney H; Mallesara G; Marx G; Stockler MR; Prime C; Parton RG; Hoy AJ; Daly RJ; Meikle PJ; Horvath LG, 2017, 'A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer', International Journal of Cancer, vol. 141, pp. 2112 - 2120, http://dx.doi.org/10.1002/ijc.30903
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Selinger CI; Li BT; Pavlakis N; Links M; Gill AJ; Lee A; Clarke S; Tran TN; Lum T; Yip PY; Horvath L; Yu B; Kohonen-Corish MRJ; O'Toole SA; Cooper WA, 2017, 'Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target', Histopathology, vol. 70, pp. 402 - 411, http://dx.doi.org/10.1111/his.13076
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG, 2017, 'Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up', BJU International, vol. 120, pp. 651 - 658, http://dx.doi.org/10.1111/bju.13857
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Zhang AY; Grogan JS; Mahon KL; Rasiah K; Sved P; Eisinger DR; Boulas J; Vasilaris A; Henshall SM; Stricker PD; Kench JG; Horvath LG, 2017, 'A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer', Annals of Oncology, vol. 28, pp. 1903 - 1909, http://dx.doi.org/10.1093/annonc/mdx247
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Valdés-Mora F; Gould CM; Colino-Sanguino Y; Qu W; Song JZ; Taylor KM; Buske FA; Statham AL; Nair SS; Armstrong NJ; Kench JG; Lee KML; Horvath LG; Qiu M; Ilinykh A; Yeo-Teh NS; Gallego-Ortega D; Stirzaker C; Clark SJ, 2017, 'Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer', Nature Communications, vol. 8, http://dx.doi.org/10.1038/s41467-017-01393-8
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Nikolic I; Elsworth B; Dodson E; Wu SZ; Gould CM; Mestdagh P; Marshall GM; Horvath LG; Simpson KJ; Swarbrick A, 2017, 'Discovering cancer vulnerabilities using high-throughput micro-RNA screening', Nucleic Acids Research, vol. 45, pp. 12657 - 12670, http://dx.doi.org/10.1093/nar/gkx1072
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Horvath L; Desai J; Sandhu S; O'Donnell A; Hill AG; Deva S; Markman B; Jameson MB; Chen Z; Tan X; Hou J; Lim A, 2017, 'Preliminary results from a subset of patients (pts) with advanced head and neck squamous carcinoma (HNSCC) in a dose-escalation and dose-expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)', Annals of Oncology, vol. 28, pp. v129 - v130, http://dx.doi.org/10.1093/annonc/mdx367.022
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB, 2017, 'Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer', Clinical Neurophysiology, vol. 128, pp. 1166 - 1175, http://dx.doi.org/10.1016/j.clinph.2017.04.009
    Journal articles | 2017
    Dr Lisa Glen Horvath
    McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB, 2017, 'Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey', Supportive Care in Cancer, vol. 25, pp. 3485 - 3493, http://dx.doi.org/10.1007/s00520-017-3772-y
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Mahon KL; Qu W; Lin H-M; Spielman C; Cain D; Jacobs C; Chi KN; De Bono JS; Higano CS; Clark SJ; Horvath L, 2017, 'Post hoc analysis of a phase III study to test the association between circulating methylated glutathione s transferase (mGSTP1) DNA levels and response to docetaxel (DTX) in metastatic castration resistant prostate cancer (mCRPC).', Journal of Clinical Oncology, vol. 35, pp. 5014 - 5014, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.5014
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Meniawy T; Richardson G; Townsend A; Desai J; Gan H; Friedlander M; Horvath L; Jameson MB; Sandhu S; Wu Z; Qin Z; Kang K; Markman B, 2017, 'Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)', Annals of Oncology, vol. 28, pp. v130 - v130, http://dx.doi.org/10.1093/annonc/mdx367.023
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Kalsbeek A; Chan E; Grogan J; Petersen D; Jaratlerdsiri W; Gupta R; Lyons R; Haynes A-M; Horvath L; Kench J; Stricker P; Hayes V, 2017, 'MP83-01 HIGH-GRADE PROSTATE CANCER HAS INCREASED MITOCHONDRIAL CONTENT', Journal of Urology, vol. 197, http://dx.doi.org/10.1016/j.juro.2017.02.2569
    Journal articles | 2017
    Dr Lisa Glen Horvath
    Kalsbeek AMF; Chan EFK; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes A-M; Horvath LG; Kench JG; Stricker PD; Hayes VM, 2017, 'Mitochondrial genome content is decreased in prostate cancer overall, but increased in high grade cancer', Pathology, vol. 49, pp. S104 - S105, http://dx.doi.org/10.1016/j.pathol.2016.12.300
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Bonilla C; Lewis SJ; Martin RM; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; Lathrop M; Smith GD; Cook M; Morga A; Lophatananon A; Fisher C; Leongamornlert D; Saunders EJ; Sawyer EJ; Govindasami K; Tymrakiewicz M; Guy M; Livni N; Wilkinson R; Jugurnauth-Little S; Hazel S; Dadaev T; Southey MC; Fitzgerald LM; Pedersen J; Hopper J; Karlsson A; Cavalli-Bjoerkman C; Johansson JE; Adolfson J; Aly M; Broms M; Stattin P; Henderson BE; Schumacher F; Auvinen A; Taari K; Maeaettaenen L; Kujala P; Murtola T; Tammela TLJ; Sipeky C; Roder MA; Iversen P; Klarskov P; Nielsen SF; Weischer M; Key TJ; Wallinder H; Gustafsson S; Cox A; George A; Lane A; Marsden G; Davis M; Brown P; Pharoah P; Signorello LB; Zheng W; McDonnell SK; Schaid DJ; Wang L; Tillmans L; Riska S; Schnoeller T; Herkommer K; Luedeke M; Vogel W; Wokozorczyk D; Lubiski J; Kluzniak W, 2016, 'Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort', BMC Medicine, vol. 14, http://dx.doi.org/10.1186/s12916-016-0602-x
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Lomax AJ; Beith J; Bhadri V; Boyer M; Grimison P; Horvath LG; Kao S; Tattersall M; Thomas D; McNeil C, 2016, 'Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse', Internal Medicine Journal, vol. 46, pp. 1392 - 1398, http://dx.doi.org/10.1111/imj.13232
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Fromm PD; Papadimitrious MS; Hsu JL; Van Kooten Losio N; Verma ND; Lo TH; Silveira PA; Bryant CE; Turtle CJ; Prue RL; Vukovic P; Munster DJ; Nagasaki T; Barnard RT; Mahler SM; Anguille SA; Berneman Z; Horvath LG; Bradstock KF; Joshua DE; Clark GJ; Hart DNJ, 2016, 'CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses', OncoImmunology, vol. 5, http://dx.doi.org/10.1080/2162402X.2016.1168555
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Kalsbeek AMF; Chan EFK; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM, 2016, 'Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer', Aging, vol. 8, pp. 2702 - 2712, http://dx.doi.org/10.18632/aging.101044
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Bruce HM; Stricker PD; Gupta R; Savdie RR; Haynes AM; Mahon KL; Lin HM; Kench JG; Horvath LG, 2016, 'Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer', Prostate, vol. 76, pp. 1491 - 1500, http://dx.doi.org/10.1002/pros.23233
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Humphrey ES; Su SP; Nagrial AM; Hochgrä Fe F; Pajic M; Lehrbach GM; Parton RG; Yap AS; Horvath LG; Chang DK; Biankin AV; Wu J; Daly RJ, 2016, 'Resolution of novel pancreatic ductal adenocarcinoma subtypes by global phosphotyrosine profiling', Molecular and Cellular Proteomics, vol. 15, pp. 2671 - 2685, http://dx.doi.org/10.1074/mcp.M116.058313
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Papadimitrious M; Fromm PD; Van Kooten Losio N; Bryant C; Clark GJ; Anguille S; Berneman ZN; Horvath L; Bradstock KF; Hart DN, 2016, 'mRNA Loaded CMRF-56 Blood Dendritic Cells Augment Anti-Cancer Immune Responses in Conjunction with Nivolumab', Cytotherapy, vol. 18, pp. S100 - S100, http://dx.doi.org/10.1016/j.jcyt.2016.03.205
    Journal articles | 2016
    Dr Lisa Glen Horvath
    Mahon KL; Lin H-M; Spielman C; Lee-Ng M; Gurney H; Mallesara G; Stockler MR; Briscoe KP; Marx GM; Breit SN; Brown DA; Horvath L, 2016, 'Phase II trial of circulating cytokines as markers of docetaxel (DTX) resistance in metastatic castrate-resistant prostate cancer (mCRPC).', Journal of Clinical Oncology, vol. 34, pp. 5039 - 5039, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.5039
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Stegeman S; Amankwah E; Klein K; O’Mara TA; Kim D; Lin HY; Permuth-Wey J; Sellers TA; Srinivasan S; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pharoah P; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Kaneva R; Teixeira MR; Spurdle AB; Clements JA; Park JY; Batra J; Cook M; Morgan A; Lophatananon A; Fisher C; Leongamornlert D; Saunders EJ; Sawyer EJ; Govindasami K; Tymrakiewicz M; Guy M; Livni N; Wilkinson R; Jugurnauth-Little S; Hazel S; Dadaev T; Pedersen J; Hopper JL; Southey MC; Karlsson A; Cavalli-Bjoerkman C; Johansson JE; Adolfson J; Aly M; Broms M; Stattin P; Henderson BE; Schumacher F; Auvinen A; Taari K; Maeaettaenen L; Kujala P; Murtola T; Tammela TLJ; Wahlfors T; Roder A; Iversen P; Klarskov P; Nielsen SF; Weischer M; Key TJ; Wallinder H; Gustafsson S; Donovan JL; Hamdy F; George A; Lane A; Marsden G; Davis M; Brown P; Pashayan N; Holt S; Signorello LB; Zheng W; Wang L; Tillmans L; Riska S; Rinckleb A; Herkommer K; Luedeke M, 2015, 'A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer', Cancer Discovery, vol. 5, pp. 368 - 379, http://dx.doi.org/10.1158/2159-8290.CD-14-1057
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Cooper WA; Tran T; Vilain RE; Madore J; Selinger CI; Kohonen-Corish M; Yip PY; Yu B; O'Toole SA; McCaughan BC; Yearley JH; Horvath LG; Kao S; Boyer M; Scolyer RA, 2015, 'PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma', Lung Cancer, vol. 89, pp. 181 - 188, http://dx.doi.org/10.1016/j.lungcan.2015.05.007
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Mahon KL; Lin HM; Castillo L; Lee BY; Lee-Ng M; Chatfield MD; Chiam K; Breit SN; Brown DA; Molloy MP; Marx GM; Pavlakis N; Boyer MJ; Stockler MR; Daly RJ; Henshall SM; Horvath LG, 2015, 'Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer', British Journal of Cancer, vol. 112, pp. 1340 - 1348, http://dx.doi.org/10.1038/bjc.2015.74
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Rynkiewicz NK; Fedele CG; Chiam K; Gupta R; Kench JG; Ooms LM; McLean CA; Giles GG; Horvath LG; Mitchell CA, 2015, 'INPP4Bis highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival', Prostate, vol. 75, pp. 92 - 102, http://dx.doi.org/10.1002/pros.22895
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Gupta R; O'Connell R; Haynes A-M; Stricker PD; Barrett W; Turner JJ; Delprado W; Horvath LG; Kench JG, 2015, 'Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?', BJU International, vol. 116, pp. n/a - n/a, http://dx.doi.org/10.1111/bju.12911
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Lee BY; Timpson P; Horvath LG; Daly RJ, 2015, 'FAK signaling in human cancer as a target for therapeutics', Pharmacology & therapeutics, vol. 146, pp. 132 - 149, http://dx.doi.org/10.1016/j.pharmthera.2014.10.001
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Nagrial AM; Chin VT; Sjoquist KM; Pajic M; Horvath LG; Biankin AV; Yip D, 2015, 'Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials', Critical Reviews in Oncology/Hematology, vol. 96, pp. 483 - 497, http://dx.doi.org/10.1016/j.critrevonc.2015.07.007
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Yates A; Carroll S; Kneebone A; Tse R; Horvath L; Byrne C; Solomon M; Hruby G, 2015, 'Implementing intensity-modulated radiotherapy with simultaneous integrated boost for anal cancer: 3 year outcomes at two Sydney institutions', Clinical Oncology, vol. 27, pp. 700 - 707, http://dx.doi.org/10.1016/j.clon.2015.08.006
    Journal articles | 2015
    Dr Lisa Glen Horvath
    Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubinski J; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lim H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Gronberg H; Wiklund F, 2015, 'Prediction of Individual Genetic Risk to Prostate Cancer Using a Polygenic Score', PROSTATE, vol. 75, pp. 1467 - 1474, http://dx.doi.org/10.1002/pros.23037
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Suttie CF; Hruby G; Horvath L; Thompson J, 2014, 'Cardiac metastasis in Merkel cell carcinoma', Journal of Clinical Oncology, vol. 32, http://dx.doi.org/10.1200/JCO.2012.48.3073
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Nagrial AM; Chang DK; Nguyen NQ; Johns AL; Chantrill LA; Humphris JL; Chin VT; Samra JS; Gill AJ; Pajic M; Pinese M; Colvin EK; Scarlett CJ; Chou A; Kench JG; Sutherland RL; Horvath LG; Biankin AV, 2014, 'Adjuvant chemotherapy in elderly patients with pancreatic cancer', British Journal of Cancer, vol. 110, pp. 313 - 319, http://dx.doi.org/10.1038/bjc.2013.722
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Sutherland SIM; Pe Benito R; Henshall SM; Horvath LG; Kench JG, 2014, 'Expression of phosphorylated-mTOR during the development of prostate cancer', Prostate, vol. 74, pp. 1231 - 1239, http://dx.doi.org/10.1002/pros.22840
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Mahon KL; Qu W; Devaney J; Paul C; Castillo L; Wykes RJ; Chatfield MD; Boyer MJ; Stockler MR; Marx G; Gurney H; Mallesara G; Molloy PL; Horvath LG; Clark SJ, 2014, 'Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer', British Journal of Cancer, vol. 111, pp. 1802 - 1809, http://dx.doi.org/10.1038/bjc.2014.463
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Galletti G; Matov A; Beltran H; Fontugne J; Miguel Mosquera J; Cheung C; Macdonald TY; Sung M; O'Toole S; Kench JG; Suk Chae S; Kimovski D; Tagawa ST; Nanus DM; Rubin MA; Horvath LG; Giannakakou P; Rickman DS, 2014, 'ERG induces taxane resistance in castration-resistant prostate cancer', Nature Communications, vol. 5, http://dx.doi.org/10.1038/ncomms6548
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Lin HM; Castillo L; Mahon KL; Chiam K; Lee BY; Nguyen Q; Boyer MJ; Stockler MR; Pavlakis N; Marx G; Mallesara G; Gurney H; Clark SJ; Swarbrick A; Daly RJ; Horvath LG, 2014, 'Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer', British Journal of Cancer, vol. 110, pp. 2462 - 2471, http://dx.doi.org/10.1038/bjc.2014.181
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Birch SE; Kench JG; Takano E; Chan P; Chan A-L; Chiam K; Veillard A-S; Stricker P; Haupt S; Haupt Y; Horvath L; Fox SB, 2014, 'Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death', Annals of Oncology, vol. 25, pp. 2392 - 2397, http://dx.doi.org/10.1093/annonc/mdu454
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Yip PY; Cooper WA; Kohonen-Corish MRJ; Lin BPC; McCaughan BC; Boyer MJ; Kench JG; Horvath LG, 2014, 'Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer', Journal of Clinical Pathology, vol. 67, pp. 333 - 340, http://dx.doi.org/10.1136/jclinpath-2013-201870
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Grimison P; Stockler MR; Yip S; Toner G; Horvath L, 2014, 'Anzup 1302 P3Bep Companion Translational Study: Prospective Collection of Whole Blood, Serum, Plasma and Tumour Tissue in a Randomized Trial of Chemotherapy for Metastatic Germ Cell Tumours (Gct)', Annals of Oncology, vol. 25, pp. iv304 - iv304, http://dx.doi.org/10.1093/annonc/mdu337.67
    Journal articles | 2014
    Dr Lisa Glen Horvath
    Cooper WA; Selinger CI; Tran TN; Pavlakis N; Yip PY; Horvath L; Kohonen-Corish MR; O'Toole S, 2014, '11. Ros1 gene rearrangements in non-small cell lung carcinoma - a new genetic target.', Pathology, vol. 46 Suppl 1, pp. S110, http://dx.doi.org/10.1097/01.PAT.0000443701.27695.95
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Selinger CI; Rogers TM; Russell PA; O'Toole S; Yip PY; Wright GM; Wainer Z; Horvath LG; Boyer M; McCaughan B; Kohonen-Corish MRJ; Fox S; Cooper WA; Solomon B, 2013, 'Testing for ALK rearrangement in lung adenocarcinoma: A multicenter comparison of immunohistochemistry and fluorescent in situ hybridization', Modern Pathology, vol. 26, pp. 1545 - 1553, http://dx.doi.org/10.1038/modpathol.2013.87
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Cooper WA; Yu B; Yip PY; Ng CC; Lum T; Farzin M; Trent RJ; Mercorella B; Clarkson A; Kohonen-Corish MRJ; Horvath LG; Kench JG; McCaughan B; Gill AJ; O'Toole SA, 2013, 'EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma', Journal of Clinical Pathology, vol. 66, pp. 744 - 748, http://dx.doi.org/10.1136/jclinpath-2013-201607
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ, 2013, 'Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer', Oncogene, vol. 32, pp. 2891 - 2899, http://dx.doi.org/10.1038/onc.2012.300
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Yip PY; Yu B; Cooper W; Selinger CI; Ng C; Kennedy C; Kohonen-Corish M; McCaughan BC; Trent RJ; Boyer MJ; Kench JG; Horvath LG; O'Toole S, 2013, 'Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma', Journal of Thoracic Oncology, vol. 8, pp. 408 - 414, http://dx.doi.org/10.1097/JTO.0b013e318283558e
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Lee BY; Hochgräfe F; Lin HM; Castillo L; Wu J; Raftery MJ; Martin Shreeve S; Horvath LG; Daly RJ, 2013, 'Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancer', Molecular Cancer Therapeutics, vol. 13, pp. 190 - 201, http://dx.doi.org/10.1158/1535-7163.MCT-13-0225-T
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Ryan C; Smith M; de Bono J; Molina A; Logothetis D; De Souza P; et A, 2013, 'Abiraterone in metastatic prostate cancer without previous chemotherapy', New England Journal of Medicine, vol. 368, pp. 138 - 148, http://dx.doi.org/10.1056/NEJMoa1209096
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Stricker PD; Selth L; Townley S; Bert A; Sutherland P; Horvath L; Goodall G; Butler L; Tilley W, 2013, 'Circulating microRNAs predict biochemical recurrence in prostate cancer patients.', British Journal of Cancer, vol. 109, pp. 641 - 650, http://dx.doi.org/10.1038/bjc.2013.369
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Harland S; Staffurth J; Molina A; Hao Y; Gagnon DD; Sternberg CN; Cella D; Fizazi K; Logothetis CJ; Kheoh T; Haqq CM; de Bono JS; Scher HI, 2013, 'Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy', EUROPEAN JOURNAL OF CANCER, vol. 49, pp. 3648 - 3657, http://dx.doi.org/10.1016/j.ejca.2013.07.144
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Horvath L; Chatfield MD; Lee-Ng M; Lin H-M; Castillo L; Breit SN; Brown DA; Molloy MP; Marx GM; Pavlakis N; Boyer MJ; Stockler MR; Wykes R; Henshall SM; Mahon KL, 2013, 'The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC).', Journal of Clinical Oncology, vol. 31, pp. e22175 - e22175, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e22175
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Sutherland S; Henshall S; Horvath L; Kench J, 2013, 'THE ROLE OF MAMMALIAN TARGET OF RAPAMYCIN (mTOR) IN THE DEVELOPMENT OF PROSTATE CANCER', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 9, pp. 49 - 50, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000329462300016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Yip PY; Cooper WA; Kohonen-Corish M; Mccaughan B; Boyer M; Kench J; Horvath LG, 2013, 'PHOSPHORYLATED-AKT EXPRESSION IS A PROGNOSTIC MARKER IN EARLY STAGE NON-SMALL CELL LUNG CANCER (NSCLC)', JOURNAL OF THORACIC ONCOLOGY, vol. 8, pp. S785 - S785, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624903324&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Yu B; Mercorella B; Irwin D; Ng CC; Hunt P; Yip PY; Kohonen-Corish M; Horvath LG; Cooper WA; Trent RJ; O'Toole S, 2013, 'SIMULTANEOUS PROFILING OF MULTIGENE MUTATIONS FOR THE EFFECTIVE AND EFFICIENT DIAGNOSIS OF NON-SMALL CELL LUNG CARCINOMA', JOURNAL OF THORACIC ONCOLOGY, vol. 8, pp. S784 - S785, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624903322&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Cooper WA; Selinger CI; Tran TN; Pavlakis N; Yip PY; Horvath LG; Kohonen-Corish M; O'Toole S, 2013, 'ROS1 GENE REARRANGEMENTS IN NON-MALL CELL LUNG CARCINOMA - A NEW GENETIC TARGET THAT CAN BE IDENTIFIED BY IMMUNOHISTOCHEMISTRY AND FISH', JOURNAL OF THORACIC ONCOLOGY, vol. 8, pp. S1251 - S1251, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624906085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Lee BY; Hochgraefe F; Lin H-M; Castillo L; Wu J; Raftery M; Shreeve SM; Horvath L; Daly R, 2013, 'Focal adhesion kinase: a mediator of docetaxel-resistance in castrate resistant prostate cancer', BJU INTERNATIONAL, vol. 112, pp. 38 - 39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000321969100100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr Lisa Glen Horvath
    Selth L; Townley S; Bert A; Stricker P; Sutherland P; Horvath L; Goodall G; Butler L; Tilley W, 2013, 'CIRCULATING microRNAs PREDICT BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 9, pp. 63 - 63, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000329462300049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Randall SA; Mckay MJ; Pascovici D; Mahon K; Horvath L; Clarke SJ; Molloy MP, 2012, 'Remarkable temporal stability of high-abundance human plasma proteins assessed by targeted mass spectrometry', Proteomics - Clinical Applications, vol. 6, pp. 626 - 634, http://dx.doi.org/10.1002/prca.201200039
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Femia G; Hardy TA; Spies JM; Horvath LG, 2012, 'Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: A case report and literature review', Asia-Pacific Journal of Clinical Oncology, vol. 8, pp. 115 - 122, http://dx.doi.org/10.1111/j.1743-7563.2012.01544.x
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG, 2012, 'High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy', BJU International, vol. 109, pp. 1794 - 1800, http://dx.doi.org/10.1111/j.1464-410X.2011.10572.x
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Fizazi K; Scher HI; Molina A; Logothetis CJ; Chi KN; Jones RJ; Staffurth JN; North S; Vogelzang NJ; Saad F; Mainwaring P; Harland S; Goodman OB; Sternberg CN; Li JH; Kheoh T; Haqq CM; de Bono JS, 2012, 'Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study', LANCET ONCOLOGY, vol. 13, pp. 983 - 992, http://dx.doi.org/10.1016/S1470-2045(12)70379-0
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Goldstein D; Spry N; Cummins MM; Brown C; Van Hazel GA; Carroll SL; Selva Nayagam S; Borg M; Ackland S; Wratten C; Shapiro J; Porter L; Hruby G; Horvath LG; Bydder S; Underhill C; Harvey JE; Gebski V, 2012, 'The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer', British Journal of Cancer, vol. 106, pp. 61 - 69, http://dx.doi.org/10.1038/bjc.2011.526
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Selinger CI; Rogers T-M; Russell P; Yip P; O’Toole S; Horvath L; Boyer M; McCaughan B; Kohonen-Corish M; Fox S; Cooper W; Solomon B, 2012, 'Testing for anaplastic lymphoma kinase (ALK) rearrangement in lung adenocarcinomas: a multicentre study', Pathology, vol. 44, pp. S95 - S95, http://dx.doi.org/10.1016/s0031-3025(16)32872-0
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Lee BY; Hochgrafe F; Raftery M; Horvath LG; Daly RJ, 2012, 'Abstract A33: Characterization of signaling pathways associated with docetaxel resistance in prostate cancer', Cancer Research, vol. 72, pp. A33 - A33, http://dx.doi.org/10.1158/1538-7445.prca2012-a33
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Yu B; Yip PY; Cooper W; Ng CC; Mercorella B; Le H; Trent R; Kohonen-Corish M; Kennedy C; McCaughan B; Kench J; Boyer M; Horvath L; O’Toole S, 2012, 'Patterns of somatic mutations in an Australian cohort of lung adenocarcinoma', Pathology, vol. 44, pp. S90 - S90, http://dx.doi.org/10.1016/s0031-3025(16)32856-2
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Yip PY; Yu B; Cooper WA; Kench JG; Boyer M; Kohonen-Corish MJ; Trent R; McCaughan B; Kennedy C; O'Toole SA; Horvath L, 2012, 'MUTATIONS IN RESECTED NODE-NEGATIVE LUNG ADENOCARCINOMA', JOURNAL OF THORACIC ONCOLOGY, vol. 7, pp. S189 - S190, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000317034900113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Cooper WA; Yu B; Yip PY; Farzin M; Clarkson A; Kohonen-Corish MJ; Horvath L; Kench JG; McCaughan B; O'Toole SA; Gill AJ, 2012, 'EGFR MUTANT SPECIFIC IMMUNOHISTOCHEMISTRY HAS HIGH SPECIFICITY BUT ONLY MODERATE SENSITIVITY FOR DETECTING COMMON ACTIVATING EGFR MUTATIONS IN LUNG ADENOCARCINOMA', JOURNAL OF THORACIC ONCOLOGY, vol. 7, pp. S162 - S162, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000317034900018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Selinger C; Rogers T; Russell P; Yip P; O'Toole S; Horvath L; Boyer M; McCaughan B; Kohonen-Corish M; Fox S; Cooper W; Solomon B, 2012, 'ANAPLASTIC LYMPHOMA KINASE (ALK) REARRANGEMENT IN LUNG ADENOCARCINOMAS - A LARGE MULTICENTRE STUDY OF FISH AND IHC.', JOURNAL OF THORACIC ONCOLOGY, vol. 7, pp. S182 - S182, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000317034900086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Chua W; Horvath L; Beale P; Clarke SJ, 2012, 'Reporting clinical trial information: Colorectal cancer trials at Sydney Cancer Centre', Internal Medicine Journal, vol. 42, pp. 416 - 421, http://dx.doi.org/10.1111/j.1445-5994.2011.02441.x
    Journal articles | 2012
    Dr Lisa Glen Horvath
    Venkateswaran LP; Butow PN; Jansen J; Wilcken NRC; Wong MK; Hui R; Szonyi G; Gebski VJ; Naganathan V; Horvath LG; Tattersall MHN, 2012, 'Decision making in older patients with advanced cancer: Does doctor know best?', Medical Journal of Australia, vol. 196, pp. 35 - 39, http://dx.doi.org/10.5694/mja11.10907
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Kench JG; Clouston DR; Delprado W; Eade T; Ellis D; Horvath LG; Samaratunga H; Stahl J; Stapleton AMF; Egevad L; Srigley JR; Delahunt B, 2011, 'Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens', Pathology, vol. 43, pp. 410 - 419, http://dx.doi.org/10.1097/PAT.0b013e328348a6b3
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Devaney J; Stirzaker C; Qu W; Song JZ; Statham AL; Patterson K; Horvath LG; Tabor B; Coolen MW; Hulf T; Kench JG; Henshall SM; Pe benito R; Haynes AM; Mayor R; Peinado M; Sutherland RL; Clark SJ, 2011, 'Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers', Cancer Epidemiology Biomarkers and Prevention, vol. 20, pp. 148 - 159, http://dx.doi.org/10.1158/1055-9965.EPI-10-0719
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Cooper W; O'Toole S; Boyer MJ; Horvath LG; Mahar A, 2011, 'What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements', Pathology, vol. 43, pp. 103 - 115, http://dx.doi.org/10.1097/PAT.0b013e28342629d
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Leighl N; Shepherd H; Butow PN; clarke SJ; Mcjannett M; Beale P; Wilken N; Moore M; Chen E; Goldstein D; Horvath LG; Knox J; Krzyzanowska M; Oza AM; Feld R; Hedley D; Xu W; Tattersall MH, 2011, 'Supporting treatment decision-making in advanced cancer: a randomized trial of a decision aid for patients considering chemotherapy in advanced colorectal cancer', Journal of Clinical Oncology, vol. 29, pp. 2077 - 2084, http://dx.doi.org/10.1200/JCO.2010.32.0754
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Mahon K; Henshall SM; Horvath LG; Sutherland RL, 2011, 'Pathways of chemotherapy resistance in castration-resistant prostate cancer', Endocrine - Related Cancer, vol. 18, pp. 103 - 123, http://dx.doi.org/10.1530/ERC-10-0343
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Yip PY; Kench JG; Rasiah KK; Benito RP; Lee CS; Stricker PD; Henshall SM; Sutherland RL; Horvath LG, 2011, 'Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer', Prostate, vol. 71, pp. 1638 - 1645, http://dx.doi.org/10.1002/pros.21381
    Journal articles | 2011
    Dr Lisa Glen Horvath
    De Bono JS; Logothetis CJ; Molina A; Fizazi K; North S; Chu L; Chi KN; Jones RJ; Goodman OB; Saad F; Staffurth JN; Mainwaring P; Harland S; Flaig TW; Hutson TE; Cheng T; Patterson H; Hainsworth JD; Ryan CJ; Sternberg CN; Ellard SL; Flechon A; Saleh M; Scholz M; Efstathiou E; Zivi A; Bianchini D; Loriot Y; Chieffo N; Thian K; Haqq CM; Scher HI, 2011, 'Abiraterone and Increased Survival in Metastatic Prostate Cancer', NEW ENGLAND JOURNAL OF MEDICINE, vol. 364, pp. 1995 - 2005, http://dx.doi.org/10.1056/NEJMoa1014618
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Mahon KL; Chatfield MD; Lee-Ng M; Breit SN; Brown DA; Molloy MP; Marx GM; Pavlakis N; Boyer MJ; Stockler MR; Wykes R; Henshall SM; Sutherland RL; Horvath L, 2011, 'Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer (CRPC).', JOURNAL OF CLINICAL ONCOLOGY, vol. 29, http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4598
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Horvath L; Mahon KL; Qu W; Devaney J; Chatfield MD; Paul C; Wykes R; Boyer MJ; Stockler MR; Marx GM; Sutherland RL; Clark SJ, 2011, 'A study of methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC).', JOURNAL OF CLINICAL ONCOLOGY, vol. 29, http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4603
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Yip PY; Cooper W; Mahar A; Kench J; Kohonen-Corish MRJ; Chatfield M; Boulghourjian A; Kennedy CW; Mccaughan B; Boyer M; Horvath L, 2011, 'MARKERS OF PROGNOSIS IN RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)', JOURNAL OF THORACIC ONCOLOGY, vol. 6, pp. S499 - S499, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208855802235&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2011
    Dr Lisa Glen Horvath
    Savdie R; Horvath L; Pebenito R; Rasiah K; Haynes AM; Stricker P; Turner J; Delprado W; Henshall S; Sutherland R; Kench J, 2011, 'High Gleason grade carcinoma at a positive margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy', BJU INTERNATIONAL, vol. 107, pp. 20 - 21, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000286596800047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2010
    Dr Lisa Glen Horvath
    Tebbutt NC; Wilson K; Gebski VJ; Cummins MM; Zannino D; Van Hazel GA; Robinson B; Broad A; Ganju V; Ackland SP; Forgeson G; Cunningham D; Saunders MP; Stockler MR; Chua Y; Zalcberg JR; Simes RJ; Price TJ; Price T; Coates A; O'Connell D; Brown C; Hague W; France A; Hicks S; James R; Masson R; O'Connell R; Pike R; Shoulder J; Stevens L; Tunney V; Vachan B; Wong N; Ackland S; Moylan E; Strickland A; Abdi E; Ransom D; Lowenthal R; Marx G; Nayagam SS; Shannon J; Goldstein D; Karapetis C; Blum R; Eek R; Ward R; Pavlakis N; Wilcken N; Burns I; Wyld D; Underhill C; Claringbold P; Liauw W; Clingan P; Jefford M; Horvath L; McKendrick J; Chong G; Boyce A; Cassidy J; Kirsten F; Clarke S; Guo Y; Innes-Rowe J; Smith A; Williams J; Tournier E; Maliepaard S; Vitullo E; Humm G; Nguyen V; Midolo P; Chorlton C; McDonald L; Oliver L; Sjursen AM; Inglis C; Marafioti T; McCourt J; Howard J; Richards A; Provis A; Rundle A; Whatman A; Emmett L; Raymond B; Byrne S; Withers E; Campbell J; Hodgkins C; Szwajcer M; Parker S; Welby S; Page F; Corker M; Wykes R; Goss C; Whitney S, 2010, 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study', Journal of Clinical Oncology, vol. 28, pp. 3191 - 3198, http://dx.doi.org/10.1200/JCO.2009.27.7723
    Journal articles | 2010
    Dr Lisa Glen Horvath
    Lubner SJ; Mahoney MR; Kolesar JL; LoConte NK; Kim GP; Pitot HC; Philip PA; Picus J; Yong WP; Horvath L; Van Hazel G; Erlichman CE; Holen KD, 2010, 'Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: A phase II consortium study', Journal of Clinical Oncology, vol. 28, pp. 3491 - 3497, http://dx.doi.org/10.1200/JCO.2010.28.4075
    Journal articles | 2010
    Dr Lisa Glen Horvath
    Thanigasalam R; Rasiah KK; Stricker PD; Haynes AM; Sutherland S; Sutherland RL; Henshall SM; Horvath LG, 2010, 'Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram', BJU International, vol. 10, pp. 642 - 647, http://dx.doi.org/10.1111/j.1464-410X.2009.08842.x
    Journal articles | 2010
    Dr Lisa Glen Horvath
    Ocean AJ; Polite B; Christos P; Horvath L; Hamilton A; Matulich D; Chen HX; Sparano JA; Kindler HL, 2010, 'Cetuximab is associated with excessive toxicity when combined with bevacizumab plus mFOLFOX6 in metastatic colorectal carcinoma', Clinical Colorectal Cancer, vol. 9, pp. 290 - 296, http://dx.doi.org/10.3816/CCC.2010.n.042
    Journal articles | 2010
    Dr Lisa Glen Horvath
    Nagrial A; Horvath L, 2010, 'Bone disease in prostate cancer', Asia-Pacific Journal of Clinical Oncology, vol. 6, pp. 3 - 4, http://dx.doi.org/10.1111/j.1743-7563.2010.01281.x
    Journal articles | 2010
    Dr Lisa Glen Horvath
    Yip P; Kench J; Rasiah K; Benito R; Lee C; Henshall S; Sutherland R; Horvath L, 2010, 'Molecular markers that predict for recurrence in men with margin-positive localized prostate cancer', JOURNAL OF CLINICAL ONCOLOGY, vol. 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.4650
    Journal articles | 2010
    Dr Lisa Glen Horvath
    Savdie R; Pe Benito RA; Haynes A-M; Stricker PD; Henshall SM; Sutherland RL; Turner JJ; Delprado W; Horvath LG; Rasiah KK; Kench JG, 2010, '300 CAN THE GLEASON GRADE AT THE SITE OF A POSITIVE MARGIN PREDICT BIOCHEMICAL FAILURE POST RADICAL PROSTATECTOMY?', Journal of Urology, vol. 183, http://dx.doi.org/10.1016/j.juro.2010.02.363
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Karim RZ; Gerega SK; Yang YH; Horvath L; Spillane A; Carmalt H; Scolyer RA; Lee CS, 2009, 'Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours', Journal of Clinical Pathology, vol. 62, pp. 1016 - 1020, http://dx.doi.org/10.1136/jcp.2009.066977
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Tattersall MH; Dear R; Jansen J; Shepherd H; Devine R; Horvath LG; Boyer MJ, 2009, 'Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre', Medical Journal of Australia, vol. 191, pp. 209 - 212, http://www.mja.com.au/public/issues/191_04_170809/tat10235_fm.pdf
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Zhao L; Lee BY; Brown DA; Molloy M; Marx GM; Pavlakis N; Boyer MJ; Stockler M; Kaplan W; Breit SN; Sutherland RL; Henshall SM; Horvath LG, 2009, 'Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling', Cancer research, vol. 69, pp. 7696 - 7703, http://dx.doi.org/10.1158/0008-5472.CAN-08-4901
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Gill A; Johns A; Eckstein R; Samra J; Kaufman A; Chang D; Merrett ND; Cosman PH; Smith RC; Biankin AV; Kench JG, 2009, 'Synoptic reporting improves histopathological assessment of pancreatic resection specimens', Pathology, vol. 41, pp. 161 - 167, http://dx.doi.org/10.1080/00313020802337329
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Balanathan P; Williams E; Wang H; Pedersen J; Horvath LG; Achen M; Stacker S; Risbridger G, 2009, 'Elevated level of inhibin-α subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer', British Journal of Cancer, vol. 100, pp. 1784 - 1793, http://dx.doi.org/10.1038/sj.bjc.6605089
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Chua W; Randall S; McKay MJ; Horvath L; Clarke SJ; Molloy MP, 2009, 'Targeted plasma proteome profiling for early prediction of chemotherapy response and toxicity in colorectal cancer (CRC)', Journal of Clinical Oncology, vol. 27, pp. e15063 - e15063, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e15063
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Moore MM; Chua W; Zhao J; Clarke SJ; Horvath L, 2009, 'Evaluation of plasma total and cleaved cytokeratin 18 as predictive markers of chemotherapy in colorectal cancer.', J Clin Oncol, vol. 27, pp. e15091, http://www.ncbi.nlm.nih.gov/pubmed/27964608
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Horvath L; Zhao L; Lee B; Brown D; Molloy M; Marx G; Boyer M; Breit S; Sutherland R; Henshall S, 2009, 'Identification of candidate biomarkers of therapeutic response to docetaxel in hormone-refractory prostate cancer by proteomic profiling.', J Clin Oncol, vol. 27, pp. 11010, http://www.ncbi.nlm.nih.gov/pubmed/27963974
    Journal articles | 2009
    Dr Lisa Glen Horvath
    Karim RZ; Gerega SK; Yang YH; Horvath L; Spillane A; Carmalt H; Scolyer RA; Lee CS, 2009, 'Proteins from the wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours', Pathology, vol. 41, pp. 60 - 61, http://dx.doi.org/10.1097/01268031-200941001-00132
    Journal articles | 2008
    Dr Lisa Glen Horvath
    Seng T; Currey N; Cooper W; Lee CS; Chan C; Horvath LG; Sutherland RL; Kennedy C; McCaughan B; Kohonen-Corish M, 2008, 'DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma', British Journal of Cancer, vol. 99, pp. 375 - 382, http://dx.doi.org/10.1038/sj.bjc.6604452
    Journal articles | 2008
    Dr Lisa Glen Horvath
    Chang DK; Merrett ND; Biankin AV, 2008, 'Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?', Journal of Gastroenterology and Hepatology, vol. 23, pp. 1036 - 1045, http://dx.doi.org/10.1111/j.1440-1746.2008.05471.x
    Journal articles | 2008
    Dr Lisa Glen Horvath
    Sakko A; Butler M; Byers S; Reinboth B; Stahl J; Kench JG; Horvath LG; Sutherland RL; Stricker PD; Henshall SM; Marshall V; Tilley WD; Horsfall DJ; Ricciardelli C, 2008, 'Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse', Cancer epidemiology biomarkers and prevention, vol. 17, pp. 2488 - 2497, http://dx.doi.org/10.1158/1055-9965.EPI-08-0204
    Journal articles | 2008
    Dr Lisa Glen Horvath
    Ho L; Kench JG; Handelsman D; Scheffer G; Stricker PD; Grygiel JJ; Sutherland RL; Henshall SM; Allen J; Horvath LG, 2008, 'Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer', Prostate, vol. 68, pp. 1421 - 1429, http://dx.doi.org/10.1002/pros.20809
    Journal articles | 2008
    Dr Lisa Glen Horvath
    Marrone J; Fairley CK; Saville M; Bradshaw C; Bowden FJ; Horvath L; Donovan BJ; Chen M; Hocking J, 2008, 'Temporal associations with declining Trichomonas vaginalis diagnosis rates among women in the state of Victoria, Australia, 1947 to 2005', Sexually Transmitted Diseases, vol. 35, pp. 572 - 576, http://dx.doi.org/10.1097/OLQ.0b013e3181666aa3
    Journal articles | 2008
    Dr Lisa Glen Horvath
    Horvath L; Thanigasalam R; Rasiah K; Stricker P; Earnest A; Haynes A; Sutherland S; Sutherland R; Henshall S, 2008, 'Stage migration and the Kattan nomogram', JOURNAL OF CLINICAL ONCOLOGY, vol. 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.5162
    Journal articles | 2007
    Dr Lisa Glen Horvath
    Horvath LG; Lelliott J; Kench JG; Soon L; Williams E; Saunders DA; Grygiel JJ; Sutherland RL; Henshall SM, 2007, 'Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer', Prostate, vol. 64 (1), pp. 1081 - 1090, http://dx.doi.org/10.1002/pros.20607
    Journal articles | 2007
    Dr Lisa Glen Horvath
    Golovsky D; Thanigasalam R; Rasiah K; Haynes AM; Sutherland S; Stricker P; Henshall S; Horvath L, 2007, 'MP-11.18: Is there evidence of a continued stage migration in the PSA screening era in an Australian population?', Urology, vol. 70, pp. 99 - 100, http://dx.doi.org/10.1016/j.urology.2007.06.401
    Journal articles | 2006
    Dr Lisa Glen Horvath
    Henshall SM; Horvath LG; Quinn DI; Eggleton SA; Grygiel JJ; Stricker PD; Biankin AV; Kench JG; Sutherland RL, 2006, 'Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy', Journal of the National Cancer Institute, vol. 98, pp. 1420 - 1424, http://dx.doi.org/10.1093/jnci/djj378
    Journal articles | 2006
    Dr Lisa Glen Horvath
    Rasiah KK; Kench JG; Gardiner-Garden M; Biankin AV; Golovsky D; Brenner PC; Kooner R; O Neill G; Turner J; Delprado W; Lee CS; Brown DA; Breit SN; Grygiel JJ; Horvath LG; Stricker PD; Sutherland RL; Henshall SM, 2006, 'Aberrant neuropepticle Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis', Cancer epidemiology biomarkers and prevention, vol. 15, pp. 711 - 716, http://dx.doi.org/10.1158/1055-9965.EPI-05-0752
    Journal articles | 2006
    Dr Lisa Glen Horvath
    Sharma R; Rivory L; Beale P; Ong S; Horvath L; Clarke SJ, 2006, 'A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer', British Journal of Cancer, vol. 94, pp. 964 - 968, http://dx.doi.org/10.1038/sj.bjc.6603049
    Journal articles | 2006
    Dr Lisa Glen Horvath
    Horvath LG; Lelliott J; Kench JG; Lee CS; Grygiel JJ; Henshall SM; Sutherland RL, 2006, 'Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer', EJC Supplements, vol. 4, pp. 120 - 120, http://dx.doi.org/10.1016/S1359-6349(06)70395-0
    Journal articles | 2005
    Dr Lisa Glen Horvath
    Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams E, 2005, 'Lymphatic vessel density and lymph node metastasis in prostate cancer', Prostate, vol. 65, pp. 222 - 230, http://dx.doi.org/10.1002/pros.20288
    Journal articles | 2005
    Dr Lisa Glen Horvath
    Horvath LG; Henshall SM; Lee CS; Kench JG; Golovsky D; Brenner PC; O Neill G; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL, 2005, 'Lower levels of nuclear b-catenin predict for a poorer prognosis in localised prostate cancer', International Journal of Cancer, vol. 113, pp. 415 - 422, http://dx.doi.org/10.1002/ijc.20599
    Journal articles | 2005
    Dr Lisa Glen Horvath
    Read JA; Beale PJ; Horvath LG; Volker D; Childs A; Smith N; Clarke SJ, 2005, 'Impact of fish-oil supplement on nutritional parameters, inflammation and chemotherapy induced toxicity in colorectal cancer (CRC) patients receiving FOLFIRI- a pilot study', Journal of Clinical Oncology, vol. 23, pp. 8243 - 8243, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.8243
    Journal articles | 2005
    Dr Lisa Glen Horvath
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED; Loberg RD; Pienta KJ, 2005, 'Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer', Urologic Oncology: Seminars and Original Investigations, vol. 23, pp. 76, http://dx.doi.org/10.1016/j.urolonc.2004.11.005
    Journal articles | 2004
    Dr Lisa Glen Horvath
    Zeng Y; Opeskin K; Baldwin M; Horvath LG; Achen M; Stacker S; Sutherland RL; Williams E, 2004, 'Expression of vascular endothelial growth factor receptor-3 bylymphatic endothelial cells is associated with lymph node metastasis inprostate cancer', Clinical Cancer Research, vol. 10, pp. 5137 - 5144, http://dx.doi.org/10.1158/1078-0432.CCR-03-0434
    Journal articles | 2004
    Dr Lisa Glen Horvath
    Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O Neill G; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL, 2004, 'Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro', Clinical Cancer Research, vol. 10, pp. 615 - 625, http://dx.doi.org/10.1158/1078-0432.CCR-0707-03
    Journal articles | 2004
    Dr Lisa Glen Horvath
    Horvath LG; Henshall SM; Kench JG; Turner JJ; Golovsky D; Brenner PC; O Neill G; Kooner R; Stricker PD; Grygiel et A, 2004, 'Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression', Prostate, vol. 59, pp. 234 - 242, http://dx.doi.org/10.1002/pros.10361
    Journal articles | 2004
    Dr Lisa Glen Horvath
    Horvath LG; Henshall SM; Lee CS; Kench JG; Stricker PD; Grygiel JJ; Sutherland RL, 2004, 'Nuclear beta-catenin as a marker of outcome in localized prostate cancer', Journal of Clinical Oncology, vol. 22, pp. 9570 - 9570, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.9570
    Journal articles | 2004
    Dr Lisa Glen Horvath
    Horvath LG; Henshall SM; Lee CS; Kench JG; Stricker PD; Grygiel JJ; Sutherland RL, 2004, 'Nuclear beta-catenin as a marker of outcome in localized prostate cancer', Journal of Clinical Oncology, vol. 22, pp. 9570 - 9570, http://dx.doi.org/10.1200/jco.2004.22.90140.9570
    Journal articles | 2004
    Dr Lisa Glen Horvath
    Rasiah KK; Kench JG; Gardiner-Garden M; Horvath LG; Biankin AV; Walsh R; Turner JJ; Lee CS; Delprado W; Golovsky D; Brenner PC; Kooner R; O'Neill GF; Stricker PD; Sutherland RL; Henshall SM, 2004, '1079: Neuropeptide Y Expression is increased in the Progression from Benign to Malignant Prostate Epithelium and Predicts Outcome after Radical Prostatectomy', Journal of Urology, vol. 171, pp. 284 - 285, http://dx.doi.org/10.1016/s0022-5347(18)38316-2
    Journal articles | 2004
    Dr Lisa Glen Horvath
    Horvath LG; Henshall SM; Lee CS; Kench JG; Stricker PD; Grygiel JJ; Sutherland RL, 2004, 'Nuclear beta-catenin as a marker of outcome in localized prostate cancer', Journal of Clinical Oncology, vol. 22, pp. 852S - 852S, http://www.ncbi.nlm.nih.gov/pubmed/28016659
    Journal articles | 2003
    Dr Lisa Glen Horvath
    Henshall SM; Afar DE; Hiller J; Horvath LG; Quinn DI; Rasiah KK; Gish K; Willhite D; Kench JG; Gardiner-Garden M; Stricker PD; Sher HI; Grygiel JJ; Agus DB; Mack DH; Sutherland RL, 2003, 'Survival analaysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse', Cancer research, vol. 63, pp. 4196 - 4203
    Journal articles | 2003
    Dr Lisa Glen Horvath
    Henshall SM; Afar DE; Rasiah KK; Horvath LG; Gish K; Caras I; Ramakrishnan V; Wong M; Jeffrey U; Kench JG; Quinn DI; Turner JI; Delprado W; Lee CM; Golovsky D; Brenner PC; O Neil G; Kooner R; Stricker PD; Grygiel JJ; Mack DH; Sutherland RL, 2003, 'Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease ot invasive prostate cancer', Oncogene, vol. 22, pp. 6005 - 6012, http://dx.doi.org/10.1038/sj.onc.1206797
    Journal articles | 2002
    Dr Lisa Glen Horvath
    Horvath LG; McCaughan BC; Stockler M; Boyer MJ, 2002, 'Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours', Internal Medicine Journal, vol. 32, pp. 79 - 83, http://dx.doi.org/10.1046/j.1445-5994.2002.00169.x
    Journal articles | 2001
    Dr Lisa Glen Horvath
    Horvath L; Henshall S, 2001, 'Timely topic: The application of tissue microarrays to cancer research', Pathology, vol. 33, pp. 125 - 129, http://dx.doi.org/10.1080/003130201200338791
    Journal articles | 2001
    Dr Lisa Glen Horvath
    Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J, 2001, 'Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer', Lung Cancer, vol. 32, pp. 173 - 178, http://dx.doi.org/10.1016/S0169-5002(00)00218-X
    Journal articles | 2001
    Dr Lisa Glen Horvath
    Horvath L; McDowell D; Stevens G; Parkinson R; McCarthy S; Boyer M, 2001, 'Case 2. Seminoma of the conus medullaris', Journal of Clinical Oncology, vol. 19, pp. 911 - 915, http://dx.doi.org/10.1200/jco.2001.19.3.911
    Journal articles | 2001
    Dr Lisa Glen Horvath
    Horvath L; Henshall S, 2001, 'The application of tissue microarrays to cancer research', PATHOLOGY, vol. 33, pp. 125 - 129, http://dx.doi.org/10.1080/003130201200338791
    Journal articles | 2001
    Dr Lisa Glen Horvath
    Afar D; Henshall S; Gish K; Horvath L; Head D; Sutherland R; Mack D, 2001, 'Identification of immunotherapeutic targets in prostate cancer by genome-wide molecular profiling.', CLINICAL CANCER RESEARCH, vol. 7, pp. 3692S - 3692S, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172121800192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2001
    Dr Lisa Glen Horvath
    Horvath L; Bayfield M; Clifford A; Painter D; Clarke S, 2001, 'Case 1. Recurrent laryngeal nerve palsy in mediastinal seminoma', Journal of Clinical Oncology, vol. 19, pp. 909 - 911, http://dx.doi.org/10.1200/jco.2001.19.3.909
    Journal articles | 1957
    Dr Lisa Glen Horvath
    PATER J; KERDO I; SEBESTYEN L; HORVATH L, 1957, 'Complex examinations on industrial hygiene in the workshops of the Hungarian Railways.', Népegészségügy, vol. 38, pp. 26 - 38
    Journal articles | 1955
    Dr Lisa Glen Horvath
    HORVATH LG, 1955, 'Effect of fatigue on city workers.', Népegészségügy, vol. 36, pp. 212 - 217
  • Conference Papers | 2021
    Dr Lisa Glen Horvath
    Niazi T; Williams S; Davis ID; Stockler MR; Martin AJ; Bracken K; Roncolato F; Horvath L; Martin J; Lim TS; Hughes S; McDermott RS; Catto JWF; Kelly PJ; McBride SM; Parulekar WR; Morgan SC; Rendon RA; Sweeney C, 2021, 'DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801)-A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.TPS266
    Conference Papers | 2021
    Dr Lisa Glen Horvath
    Fizazi K; Mella PG; Castellano D; Minatta JN; Rezazadeh A; Shaffer DR; Vazquez Limon JC; Sanchez Lopez HM; Armstrong AJ; Horvath L; Dzik C; Amin NP; Li J; Unsal-Kacmaz K; Retz M; Saad F; Petrylak DP; Pachynski RK, 2021, 'CheckMate 9KD Arm B final analysis: Efficacy and safety of nivolumab plus docetaxel for chemotherapy-naive metastatic castration-resistant prostate cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.12
    Conference Papers | 2021
    Dr Lisa Glen Horvath
    Kelly WK; Pook DW; Appleman LJ; Waterhouse DM; Horvath L; Edenfield WJ; Matsubara N; Danila DC; Aggarwal RR; Petrylak DP; Sartor OA; Sumey CJ; Adra N; Armstrong AJ; Cheng F-C; Stieglmaier J; Kouros-Mehr H; Dorff TB, 2021, 'Phase I study of AMG 509, a STEAP1 x CD3 T-cell recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.TPS183
    Conference Papers | 2021
    Dr Lisa Glen Horvath
    Kwan EM; Dai C; Fettke H; Hauser C; Bukczynska P; Ng N; Foroughi S; Graham L-JK; Mahon KL; Tan W; Wang A; Zhao Z; Zheng T; Zhou K; Yu J-J; Du P; Horvath L; Jia S; Kohli M; Azad A, 2021, 'Plasma cell-free DNA profiling of PI3K/Akt pathway aberrations in two multi-institutional independent metastatic castration-resistant prostate cancer (mCRPC) cohorts.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.159
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Stradella A; Johnson M; Goel S; Chandana SR; Galsky MD; Calvo E; Moreno V; Park H; Arkenau T; Cervantes A; Farinas-Madrid L; Mileshkin L; Fu S; Plummer R; Evans J; Horvath L; Prawira A; Qu K; Pelham R; Barve MA, 2020, 'Clinical benefit in biomarker-positive patients (pts) with locally advanced or metastatic solid tumours treated with the PARP1/2 inhibitor pamiparib in combination with low-dose (LD) temozolomide (TMZ)', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 31, pp. S465 - S466, presented at ESMO Virtual Congress, ELECTR NETWORK, 19 September 2020 - 18 October 2020, http://dx.doi.org/10.1016/j.annonc.2020.08.644
    Conference Papers | 2020
    Dr Lisa Glen Horvath
    Tran B; Horvath L; Dorff T; Rettig M; Lolkema MP; Machiels J-P; Rottey S; Autio K; Greil R; Adra N; Lemech C; Minocha M; Cheng F-C; Kouros-Mehr H; Fizazi K, 2020, 'Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE (R)) immune therapy for metastatic castration-resistant prostate cancer (mCRPC)', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, pp. S507 - S507, presented at ESMO Virtual Congress, ELECTR NETWORK, 19 September 2020 - 18 October 2020, http://dx.doi.org/10.1016/j.annonc.2020.08.869
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Niazi T; Williams S; Davis ID; Stockler MR; Martin A; Bracken K; Roncolato F; McJannett M; Horvath L; Sengupta S; Hughes S; McDermott R; Catto J; Kelly P; Vapiwala N; Parulekar WR; Morgan S; Rendon RA; Sweeney C, 2020, 'DASL-HiCaP: Darolutamide augments standard therapy for localised very high-risk cancer of the prostate (ANZUP1801). A randomised phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 31, pp. S548 - S549, presented at ESMO Virtual Congress, ELECTR NETWORK, 19 September 2020 - 18 October 2020, http://dx.doi.org/10.1016/j.annonc.2020.08.2088
    Conference Papers | 2020
    Dr Lisa Glen Horvath
    Tran B; Horvath L; Dorff TB; Greil R; Machiels J-PH; Roncolato F; Autio KA; Rettig M; Fizazi K; Lolkema MP; Fermin AC; Salvati M; Kouros-Mehr H, 2020, 'Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy targeting prostate-specific membrane antigen (PSMA), in patients with metastatic castration-resistant prostate cancer (mCRPC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA, 13 February 2020 - 15 February 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000529525900014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Kelly WK; Danila DC; Edenfield WJ; Aggarwal RR; Petrylak DP; Sartor AO; Sumey CJ; Dorff TB; Yu EY; Adra N; Waterhouse DM; Armstrong AJ; Horvath L; Pook DW; Appleman LJ; Lau A; Salvati M; Kouros-Mehr H, 2020, 'Phase I study of AMG 509, a STEAP1 x CD3 T cell-recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 38, pp. TPS5589 - TPS5589, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.tps5589
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Kwan EM; Fettke H; Bukczynska P; Ng N; Hauser C; Graham L-JK; Mahon KL; Dai C; Xie F; Wang X; Zhao Z; Zhou K; Du P; Yu J; Jia S; Tan W; Horvath L; Kohli M; Azad A, 2020, 'Plasma cell-free DNA (cfDNA) profiling of copy number variation (CNV) to identify poor prognostic biomarkers in metastatic castration-resistant prostate cancer (mCRPC).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 38, pp. 176 - 176, http://dx.doi.org/10.1200/jco.2020.38.6_suppl.176
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Tran B; Horvath L; Rettig M; Fizazi K; Lolkema MP; Dorff TB; Greil R; Machiels J-PH; Autio KA; Rottey S; Adra N; Garje R; Roncolato F; Tagawa ST; Shariat SF; Salvati M; Poon S; Kouros-Mehr H, 2020, 'Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 38, pp. TPS5590 - TPS5590, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.tps5590
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Kelly WK; Danila DC; Edenfield WJ; Aggarwal RR; Petrylak DP; Sartor AO; Sumey CJ; Dorff TB; Yu EY; Adra N; Waterhouse DM; Armstrong AJ; Horvath L; Pook DW; Appleman LJ; Lau A; Salvati M; Kouros-Mehr H, 2020, 'Phase I study of AMG 509, a STEAP1 x CD3 T cell-recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 38, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368309163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Ben T; Horvath L; Rettig M; Fizazi K; Lolkema MP; Dorff TB; Greil R; Machiels J-PH; Autio KA; Rottey S; Adra N; Garje R; Roncolato F; Tagawa ST; Shariat SF; Salvati M; Poon S; Kouros-Mehr H, 2020, 'Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 38, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368309164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Horvath LG; Lin H-M; Mak B; Mahon K; Yeung N; Docanto M; Sutherland P; Shepherd A; Tan W; Azad A; Kohli M; Meikle P; Butler L, 2020, 'Lipidomic analysis of circulating lipids across the natural history of prostate cancer identifies aberrant ceramide metabolism', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-4761
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Kwan EM; Fettke H; Bukczynska P; Ng N; Hauser C; Graham L-JK; Mahon KL; Dai C; Xie F; Wang X; Zhao Z; Zhou K; Du P; Yu J; Jia S; Tan W; Horvath L; Kohli M; Azad A, 2020, 'Plasma cell-free DNA (cfDNA) profiling of copy number variation (CNV) to identify poor prognostic biomarkers in metastatic castration-resistant prostate cancer (mCRPC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 38, presented at Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA, 13 February 2020 - 15 February 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000529525900245&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Dr Lisa Glen Horvath
    Butler LM; Mah CY; Dehairs J; Vincent A; Mutuku S; Spotbeen X; Das R; Nassar Z; Selth L; Trim P; Snel M; Lynn D; Horvath L; Tilley W; Centenera M; Swinnen J, 2020, 'Phospholipid profiling of clinical prostate tissues reveals targetable alterations in membrane lipid composition accompanying tumorigenesis', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-2076
    Conference Papers | 2020
    Dr Lisa Glen Horvath
    Dorff T; Rettig M; Machiels J-P; Lolkema M; Autio K; Greil R; Rottey S; Adra N; Salvati M; Poon S; Tan D; Jurida G; Kouros-Mehr H; Fizazi K; Tran B; Horvath L, 2020, 'PHASE 1 STUDY OF AMG 160, A HALF-LIFE EXTENDED BITE (R) (BISPECIFIC T-CELL ENGAGER) THERAPY TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN, IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMJ PUBLISHING GROUP, pp. A207 - A208, http://dx.doi.org/10.1136/jitc-2020-SITC2020.0340
    Conference Papers | 2020
    Dr Lisa Glen Horvath
    Price TJ; Burge M; Chantrill L; Chua YJ; Horvath L; McLachlan S-A; Pavlakis N; Shapiro J; Thavaneswaran S; Tran B; Yip D; Tancock G, 2020, 'Safety and efficacy of trifluridine/tipiracil (FTD/TPI) in previously treated metastatic colorectal cancer (mCRC): Results from the Australian cohort of the phase IIIb, international, open-label, early-access PRECONNECT study', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, pp. S1283 - S1283, presented at ESMO Asia Virtual Congress, ELECTR NETWORK, 20 November 2020 - 22 November 2020, http://dx.doi.org/10.1016/j.annonc.2020.10.127
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Scheinberg T; Goodwin A; Ip E; Linton A; Mak B; Smith DP; Stockler M; Strach M; Tran B; Young AL; Zhang A; Mahon K; Horvath L, 2020, 'Evaluation of a mainstream model of genetic testing for men with prostate cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 16, pp. 40 - 41, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000594482700020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Li T; Timmins H; McCrary J; Trinh T; Friedlander M; Horvath L; Kiernan M; Goldstein D; Park S, 2020, 'Patient reported outcome scores used in chemotherapy-induced peripheral neuropathy: Defining minimal important differences', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 481 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Lisa Glen Horvath
    Voskoboynik M; Richardson GE; Mileshkin LR; McNeil CM; Horvath L; Benedetti FM; Choy GS; Sankar N; McCurry S; Zhang X; Gao M; Shah AK; Millward M, 2020, 'A phase I study of APL-501, an anti-PD-1 antibody, in patients with recurrent or advanced solid tumors.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 38, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368305113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Lisa Glen Horvath
    Mahon KL; Lin H-M; Lee-Ng M; Stockler MR; Gurney H; Mallesara G; Briscoe KP; Marx GM; Higano CS; De Bono JS; Chi KN; Brown D; Breit SN; Horvath L, 2019, 'Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration-resistant prostate cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 37, presented at ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco, CA, 28 February 2019 - 02 March 2019, http://dx.doi.org/10.1200/JCO.2019.37.7_suppl.230
    Conference Abstracts | 2019
    Dr Lisa Glen Horvath
    Powderly JD; de Souza PL; Gutierrez R; Horvath L; Seitz L; Ashok D; Park A; Walters MJ; Karakunnel JJ; Berry W; Rieger A; Garofalo A; Lai DW; Chaudhry A, 2019, 'AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced tumors: Preliminary results from ongoing phase I studies.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.2604
    Conference Papers | 2019
    Dr Lisa Glen Horvath
    Stockler MR; Martin AJ; Dhillon H; Davis ID; Chi KN; Chowdhury S; Horvath LG; Lawrence NJ; Marx GM; Mc Caffrey J; McDermott R; North SA; Parnis F; Pook DW; Reaume MN; Sandhu SK; Tan TH; Thomson A; Zielinski R; Sweeney CJ, 2019, 'Health-related quality of life (HRQL) in a randomized phase III trial of enzalutamide with standard first-line therapy for metastatic, hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led, international, co-operative group trial', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. 886 - +, presented at 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 27 September 2019 - 01 October 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295500177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Dr Lisa Glen Horvath
    Scheinberg T; Kench J; Stockler M; Mahon KL; Sebastian L; Stricker P; Joshua AM; Woo H; Thanigasalam R; Ahmadi N; Centenera MM; Butler LM; Horvath LG, 2019, 'Pharmacodynamics Effects of CDK4/6 Inhibitor LEE011 (Ribociclib) in High-Risk, Localised Prostate Cancer: A Study Protocol for a Randomised Controlled Phase II Trial (Leep Study)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 64 - 64, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476915200064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Dr Lisa Glen Horvath
    Horvath L; Armstrong AJ; Szmulewitz R; Petrylak D; Villers A; Azad A; Alcaraz A; Alekseev B; Iguchi T; Shore ND; Rosbrook B; Sugg J; Baron B; Chen L; Stenzl A, 2019, 'Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 32 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476915200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Dr Lisa Glen Horvath
    Desai J; Markman B; Friedlander M; Gan H; Horvath L; Townsend A; Millward M; Jameson M; Yen C-J; Hou M-M; Hou J; Wu J; Liang L; Deva S, 2019, 'Abstract CT084: Long-term exposure (LTE) to Tislelizumab, an investigational anti-PD-1 antibody, in a first-in-human Phase I study', in Clinical Trials, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-ct084
    Conference Abstracts | 2019
    Dr Lisa Glen Horvath
    Desai J; Markman B; Friedlander M; Gan H; Horvath L; Townsend A; Millward M; Jameson M; Yen C-J; Hou M-M; Hou J; Wu J; Liang L; Deva S, 2019, 'Long-term exposure (LTE) to Tislelizumab, an investigational anti-PD-1 antibody, in a first-in-human Phase I study', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Atlanta, GA, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-CT084
    Conference Abstracts | 2019
    Dr Lisa Glen Horvath
    Millward M; Gan HK; Joshua AM; Kuo JC-Y; Prawira A; Richardson GE; Barbee SD; Inamdar SP; Pierce KL; Qureshi M; Horvath L, 2019, 'FPT155-001: A phase Ia/Ib study of FPT155 (CD80-FC) in patients with advanced solid tumors.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 37, presented at ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco, CA, 28 February 2019 - 02 March 2019, http://dx.doi.org/10.1200/JCO.2019.37.8_suppl.TPS42
    Conference Abstracts | 2019
    Dr Lisa Glen Horvath
    Mak B; Mahon KL; Stockler MR; Joshua AM; Zhang AY; Parnis F; Meikle P; Horvath L, 2019, 'Modulation of plasma lipidomic signature in metastatic castration-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 37, presented at ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco, CA, 28 February 2019 - 02 March 2019, http://dx.doi.org/10.1200/JCO.2019.37.7_suppl.TPS331
    Conference Abstracts | 2019
    Dr Lisa Glen Horvath
    Coward J; Gan H; Kuo J; Millward M; Richardson G; Deng W; Mitra S; Schmidt M; Xiang H; Horvath L; Prawira A, 2019, 'A phase 1 study of FPT155, a first-in-class CD80 extracellular domain-Fc fusion protein, in patients with advanced solid tumors', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMC, Vol. 7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000496473200862&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Lisa Glen Horvath
    Tran B; Kouros-Mehr H; Fermin A; Horvath L; Roncolato F; Rettig M; Dorff T; Tagawa ST; Subudhi SK; Antonarakis ES; Armstrong AJ; Petrylak DP; Fizazi K; Salvati ME; Scher HI, 2019, 'A phase I study of AMG 160, a half-life extended bispecific T cell engager (HLE BiTE) immuno-oncology therapy targeting PSMA, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, Vol. 30, pp. 353 - 353, presented at 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 27 September 2019 - 01 October 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295502322&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Dr Lisa Glen Horvath
    Stradella A; Johnson ML; Goel S; Chandana SR; Galsky MD; Calvo E; Moreno V; Park H; Arkenau H-T; Cervantes A; Farinas Madrid L; Mileshkin L; Plummer R; Evans J; Horvath L; Prawira A; Pelham RJ; Mu S; Andreu-Vieyra C; Barve M, 2019, 'Updated results of the PARP1/2 inhibitor pamiparib in combination with low-dose (Id) temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumours', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. 166 - +, presented at 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 27 September 2019 - 01 October 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295501268&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Dr Lisa Glen Horvath
    Sutherland S; Abadir E; Kong B; Stockler M; Mahon K; Silveira P; Horvath L; Clark G, 2019, 'Novel Targets for an In Vivo DC Anti-Prostate Cancer Vaccine', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 64 - 65, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476915200065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Dr Lisa Glen Horvath
    Mahon KL; Stricker P; Kench J; Grogan J; Delprado W; Turner J; Horvath L; Quinn DI, 2018, 'P53 as a predictor of clinical outcome in localized prostate cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, San Francisco, CA, Vol. 36, presented at Genitourinary Cancers Symposium, San Francisco, CA, 08 February 2018 - 10 February 2018, http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.57
    Conference Abstracts | 2018
    Dr Lisa Glen Horvath
    Zhang AY; Chiam K; Haupt Y; Fox SB; Birch S; Tilley W; Butler L; Knudsen KE; Cornstock C; Rasiah K; Grogan J; Mahon KL; Bianco-Miotto T; Bohm M; Henshall SM; Delprado W; Stricker P; Horvath L; Kench J, 2018, 'An analysis of multiple biomarkers to better predict prostate cancer metastasis and death after radical prostatectomy.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, San Francisco, CA, Vol. 36, presented at Genitourinary Cancers Symposium, San Francisco, CA, 08 February 2018 - 10 February 2018, http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.54
    Conference Abstracts | 2018
    Dr Lisa Glen Horvath
    Horvath LG; Mahon KL; Qu W; Lin HM; Spielman C; Cain D; Jacobs C; Stockler MR; de Bono JS; Higano CS; Chi KN; Clark SJ, 2018, 'Post Hoc Analysis of a Phase III Study to Test the Association Between Circulating Methylated Glutathione S Transferase (mGSTP1) DNA Levels and Response to Docetaxel (DTX) in Metastatic Castration-Resistant Prostate Cancer (mCRPC)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 51 - 52, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000439493100013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Dr Lisa Glen Horvath
    To S; Kwan E; Fettke H; Docanto M; Ng N; Mant A; Parente P; Pezaro C; Horvath L; Graham L; Todenhofer T; Azad A, 2018, 'Abstract A098: Whole blood assay for rapid detection of AR-v7 in metastatic castration-resistant prostate cancer: No correlation with response to androgen-axis targeting agents', in Oral Presentations - Proffered Abstracts, American Association for Cancer Research, presented at Abstracts: AACR Special Conference: Prostate Cancer: Advances in Basic, Translational, and Clinical Research; December 2-5, 2017; Orlando, Florida, http://dx.doi.org/10.1158/1538-7445.prca2017-a098
    Conference Papers | 2018
    Dr Lisa Glen Horvath
    Kwan EM; To SQ; Fettke HC; Mant AM; Docanto MM; Bukczynska P; Ng N; Graham L-JK; Parente P; Pezaro CJ; Mahon KL; Horvath L; Todenhofer T; Azad A, 2018, 'Correlating whole blood AR-V7 and AR-V9 with therapy response to AR-targeted therapies in metastatic castrate-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.e17070
    Conference Abstracts | 2018
    Dr Lisa Glen Horvath
    Kwan EM; To S; Fettke H; Mant AM; Docanto M; Martelotto L; Bukczynska P; Ng N; Graham L-J; Parente P; Pezaro CJ; Mahon KL; Horvath L; Todenhofer T; Azad A, 2018, 'Whole blood AR-V7 and AR-V9 mRNA expression and treatment response in metastatic castrate-resistant prostate cancer (mCRPC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 36, presented at Genitourinary Cancers Symposium, San Francisco, CA, 08 February 2018 - 10 February 2018, http://dx.doi.org/10.1200/JCO.2018.36.6_suppl.252
    Conference Abstracts | 2018
    Dr Lisa Glen Horvath
    Price TJ; Falcone A; Chantrill L; Horvath L; Chua YJ; Burge M; McLachlan S-A; Van Hazel G; Pavlakis N; Shapiro J; Taieb J; Seitz JF; Wyrwicz L; Becquart M; Moreno S; Mounedji N; Van Cutsem E, 2018, 'Baseline Patient Characteristics in the International, Open-Label, Preconnect Study of Trifluridine/Tipiracil in Previously Treated Metastatic Colorectal Cancer (PHASE-IIIB)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 71 - 72, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000439493100050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Dr Lisa Glen Horvath
    Mahon K; Stricker P; Kench J; Grogan J; Delprado W; Turner J; Horvath L; Quinn D, 2018, 'P53 as a Predictor of Clinical Outcome in Localised Prostate Cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 65 - 66, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000439493100038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Dr Lisa Glen Horvath
    Shinde R; Honeyball F; van Leeuwen P; Quinn DI; Asher R; Haynes A-M; Kench JG; Stricker PD; Horvath LG, 2018, 'The Clinical Impact of Treating Localised Prostate Cancer - The Australian Experience', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 47 - 47, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437670700052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Lisa Glen Horvath
    Desai J; Gan H; Barrow C; Jameson MB; Solomon B; Atkinson V; Haydon A; Millward M; Begbie S; Brown M; Markman B; Patterson W; Hill A; Horvath L; Nagrial A; Richardson G; Jackson C; Friedlander M; Gibbs D; Parente P; Yang J; Wang L; Chen Y; Luo L, 2017, 'Abstract CT002: A Phase IB study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors', in Clinical Trials, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC, http://dx.doi.org/10.1158/1538-7445.am2017-ct002
    Conference Abstracts | 2017
    Dr Lisa Glen Horvath
    Timmins HC; Li T; Kiernan MC; Horvath LG; Harrison M; Grimison P; Cox KM; Boyle FM; Goldstein D; Park SB, 2017, 'NEUROPHYSIOLOGICAL MEASURES CORRELATE WITH PATIENT REPORTED SYMPTOMS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, Sitges, SPAIN, Vol. 22, pp. 395 - 396, presented at Peripheral-Nerve-Society Meeting, Sitges, SPAIN, 08 July 2017 - 12 July 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Lisa Glen Horvath
    Meniawy T; Richardson G; Townsend A; Desai J; Gan H; Friedlander M; Horvath L; Jameson MB; Sandhu S; Wu Z; Qin Z; Kang K; Markman B, 2017, 'Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Madrid, SPAIN, presented at 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, SPAIN, 08 September 2017 - 12 September 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324001049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Dr Lisa Glen Horvath
    Zhang A; Grogan J; Mahon K; Rasiah K; Sved P; Eisinger D; Boulas J; Vasilaris A; Henshall S; Stricker P; Kench J; Horvath L, 2017, 'A PROSPECTIVE MULTI-CENTER PHASE III VALIDATION STUDY OF AZGP1 AS A BIOMARKER IN LOCALISED PROSTATE CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 64 - 64, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427541700115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Dr Lisa Glen Horvath
    Lin HM; Mahon KL; Spielman C; Gurney H; Mallesara G; Stockler M; Briscoe K; Marx G; Horvath LG, 2016, 'Validation of circulating microRNA biomarkers of docetaxel outcome in castration-resistant prostate cancer', in BJU INTERNATIONAL, WILEY-BLACKWELL, Melbourne, AUSTRALIA, Vol. 118, pp. 22 - 22, presented at 17th Asia-Pacific Prostate Cancer Conference, Melbourne, AUSTRALIA, 31 August 2016 - 03 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000381708200046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Dr Lisa Glen Horvath
    Mahon K; Lin HM; Spielman C; Lee-Ng M; Gurney H; Mallesara G; Stockler M; Briscoe K; Marx G; Breit SN; Brown DA; Horvath LG, 2016, 'Phase II trial of circulating cytokines as markers of docetaxel resistance in metastatic castrateresistant prostate cancer (mCRPC)', in BJU INTERNATIONAL, WILEY-BLACKWELL, Melbourne, AUSTRALIA, Vol. 118, pp. 21 - 21, presented at 17th Asia-Pacific Prostate Cancer Conference, Melbourne, AUSTRALIA, 31 August 2016 - 03 September 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000381708200045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Dr Lisa Glen Horvath
    Mahon K; Lin H-M; Spielman C; Lee-Ng M; Gurney H; Mallesara G; Stockler M; Briscoe K; Marx G; Breit SN; Brown D; Horvath L, 2016, 'PHASE II TRIAL OF CIRCULATING CYTOKINES AS MARKERS OF DOCETAXEL RESISTANCE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (mCRPC)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 37 - 37, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380004900039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr Lisa Glen Horvath
    Mahon KL; Qu W; Devaney J; Paul C; Castillo L; Wykes R; Chatfield MD; Boyer MJ; Stockler MR; Marx GM; Gurney H; Gowda GMH; Molloy P; Horvath L; Clark SJ, 2014, 'Methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (CRPC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium, San Francisco, CA, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.11
    Conference Papers | 2014
    Dr Lisa Glen Horvath
    Zhang AY; Butler LM; Stricker PD; Kench JG; Tilley WD; Sebastian L; Stockler M; Horvath L, 2014, 'PHARMACODYNAMIC EFFECTS OF THE HEAT SHOCK PROTEIN 90 (HSP90) INHIBITOR, AUY922, IN HIGH-RISK, LOCALISED PROSTATE CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 46 - 46, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr Lisa Glen Horvath
    Nagrial A; Chin V; Steinmann A; Chou A; Grimmond S; Horvath L; Pajic M; Biankin A, 2014, 'GENOMIC CLASSIFIER FOR PANCREATIC DUCTAL ADENOCARCINOMA THERAPEUTIC RESPONSE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 44 - 44, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716500009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr Lisa Glen Horvath
    Mahon KL; Chiam K; Lee BY; Nguyen Q; Boyer MJ; Stockler M; Pavlakis N; Marx G; Mallesara G; Gurney H; Clark S; Swarbrick A; Daly R; Horvath L, 2014, 'CIRCULATING MICRORNAS ASSOCIATED WITH DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 26 - 27, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Dr Lisa Glen Horvath
    Horvath L; Chatfield MD; Lee-Ng M; Lin H-M; Castillo L; Breit SN; Brown DA; Molloy MP; Marx GM; Pavlakis N; Boyer MJ; Stockier MR; Wykes R; Henshall SM; Mahon KL, 2013, 'The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May 2013 - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419605294&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Dr Lisa Glen Horvath
    Mahon K; Chatfield M; Breit S; Brown D; Molloy M; Marx G; Pavlakis N; Boyer M; Stockler M; Horvath L, 2013, 'The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)', in BJU INTERNATIONAL, WILEY-BLACKWELL, pp. 30 - 31, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000321969100078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Dr Lisa Glen Horvath
    Lee BY; Hochgraefe F; Lin HM; Castillo L; Raftery M; Horvath LG; Daly RJ, 2012, 'Overcoming Docetaxel Resistance in Prostate Cancer by Targeting FAK Phosphorylation, and Its Mode of Action', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, European Org Res & Treatment Canc (EORTC), Dublin, IRELAND, pp. 48 - 49, presented at 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, European Org Res & Treatment Canc (EORTC), Dublin, IRELAND, 06 November 2012 - 09 November 2012, http://dx.doi.org/10.1016/S0959-8049(12)71956-1
    Conference Papers | 2009
    Dr Lisa Glen Horvath
    Moore MM; Chua W; Zhao J; Clarke SJ; Horvath L, 2009, 'Evaluation of plasma total and cleaved cytokeratin 18 as predictive markers of chemotherapy in colorectal cancer', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Orlando, FL, presented at 45th Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando, FL, 29 May 2009 - 02 June 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606601162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2008
    Dr Lisa Glen Horvath
    Thanigasalam R; Rasiah KK; Stricker PD; Earnest A; Haynes AM; Sutherland S; Sutherland RL; Henshall SM; Horvath LG, 2008, 'Analysis of stage migration in localised prostate cancer in Australia and its impact on the post radical prostatectomy Kattan nomogram', in British Journal of Urology, WILEY-BLACKWELL, Hong Kong, PEOPLES R CHINA, pp. 35 - 35, presented at British Journal of Urology, Hong Kong, PEOPLES R CHINA, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000252815500114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Awards

Grants

Media